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A B S T R A C T
Background
Approximately 25% of people will be affected by a mental disorder at some stage in their life. Despite the prevalence and negative
impacts of mental disorders, many people are not diagnosed or do not receive adequate treatment. Therefore primary health care has
been identified as essential to improving the delivery of mental health care. Consultation liaison is a model of mental health care where
the primary care provider maintains the central role in the delivery of mental health care with a mental health specialist providing
consultative support. Consultation liaison has the potential to enhance the delivery of mental health care in the primary care setting
and in turn improve outcomes for people with a mental disorder.
Objectives
To identify whether consultation liaison can have beneficial effects for people with a mental disorder by improving the ability of primary
care providers to provide mental health care.
Search methods
We searched the EPOC Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL), and bibliographic databases:
MEDLINE, EMBASE, CINAHL and PsycINFO, in March 2014. We also searched reference lists of relevant studies and reviews to
identify any potentially relevant studies.
Selection criteria
We included randomised controlled trials (RCTs) which compared consultation liaison to standard care or other service models of
mental health care in the primary setting. Included participants were people attending primary care practices who required mental
health care or had a mental disorder, and primary care providers who had direct contact with people in need of mental health care.
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Data collection and analysis
Two review authors independently screened the titles and abstracts of identified studies against the inclusion criteria and extracted
details including the study design, participants and setting, intervention, outcomes and any risk of bias. We resolved any disagreements
by discussion or referral to a third author. We contacted trial authors to obtain any missing information.
We collected and analysed data for all follow-up periods: up to and including three months following the start of treatment; between
three and 12 months; and more than 12 months following the start of therapy.
We used a random-effects model to calculate the risk difference (RD) for binary data and number needed to treat for an additional
beneficial outcome (NNTB), if differences between groups were significant. The mean difference (MD) or standardised mean difference
(SMD) was calculated for continuous data.
Main results
There were 8203 citations identified from database searches and reference lists. We included 12 trials with 2605 consumer participants
andmore than 905 primary care practitioner participants. Eleven trials compared consultation liaison to standard care and one compared
consultation liaison to collaborative care, with a case manager co-ordinating mental health care. People with depression were included
in eight trials; and one trial each included people with a variety of disorders: depression, anxiety and somatoform disorders; medically
unexplained symptoms; and drinking problems. None of the included trials reported separate data for children or older people.
There was some evidence that consultation liaison improved mental health up to three months following the start of treatment (two
trials, n = 445, NNTB 8, 95% CI 5 to 25) but there was no evidence of its effectiveness between three and 12 months. Consultation
liaison also appeared to improve consumer satisfaction (up to three months: one trial, n = 228, NNTB 3, 95% CI 3 to 5; 3 to 12
months: two trials, n = 445, NNTB 8, 95% CI 5 to 17) and adherence (3 to 12 months: seven trials, n = 1251, NNTB 6, 95% CI 4 to
13) up to 12 months. There was also an improvement in the primary care provider outcomes of providing adequate treatment between
three to 12 months (three trials, n = 797, NNTB 7, 95% CI 4 to 17) and prescribing pharmacological treatment up to 12 months
(four trials, n = 796, NNTB 13, 95% CI 7 to 50). There was also some evidence that consultation liaison may not be as effective as
collaborative care in regards to symptoms of mental disorder, disability, general health status, and provision of treatment.
The quality of these findings were low for all outcomes however, apart from consumer adherence from three to 12 months, which was
of moderate quality. Eight trials were rated a high risk of performance bias because consumer participants were likely to have known
whether or not they were allocated to the intervention group and most outcomes were self reported. Bias due to attrition was rated
high in eight trials and reporting bias was rated high in six.
Authors’ conclusions
There is evidence that consultation liaison improves mental health for up to three months; and satisfaction and adherence for up to 12
months in people with mental disorders, particularly those who are depressed. Primary care providers were also more likely to provide
adequate treatment and prescribe pharmacological therapy for up to 12 months. There was also some evidence that consultation liaison
may not be as effective as collaborative care in terms of mental disorder symptoms, disability, general health status, and provision of
treatment. However, the overall quality of trials was low particularly in regards to performance and attrition bias and may have resulted
in an overestimation of effectiveness. More evidence is needed to determine the effectiveness of consultation liaison for people with
mental disorders particularly for those with mental disorders other than depression.
P L A I N L A N G U A G E S U M M A R Y
Consultation liaison in primary care appears to improve mental health practice and outcomes for people with a mental disorder
Despite the prevalence and negative impacts of mental disorders, many people are not diagnosed or do not receive adequate treatment.
Consultation liaison is one way of providing mental health care to people in the primary care setting. In consultation liaison, a mental
health specialist works with the primary care provider to deliver appropriate care for people with mental health needs. In this review of
studies published up till March 2014, the effectiveness of consultation liaison was compared to standard primary care and other types
of mental health care. We included 12 trials with 2605 consumers and more than 905 primary care providers. Consultation liaison
was compared to standard care in 11 trials, and compared to collaborative care in one trial. Collaborative care is mental health care co-
ordinated by a primary care case manager. There was some evidence that consultation liaison improved mental health, satisfaction with
care and adherence to treatment in people with some mental disorders, particularly those with depression, and improved mental health
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care by primary care providers. There was also some evidence suggesting consultation liaison may not be as effective as collaborative
care. However, as the overall quality of trials was low, the effectiveness of these ways of delivering care may have been overestimated. No
conclusions can be made regarding the use of consultation liaison with people who have other mental disorders such as schizophrenia
or bipolar disorder. There was also no data which could inform practice with specific groups of people such as children and adolescents,
and the elderly. More high quality trials of consultation liaison are needed.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Consultation liaison versus standard care for mental disorders
Patient or population: Patients with mental disorders
Settings: Primary care
Intervention: Consultat ion liaison versus standard care
Outcomes Illustrative comparative risks* (95% CI) Effect size
(95% CI)
No. of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Standard care Consultation liaison
Improvement in mental
health - up to 3 months
Study population
Consultat ion liaison may improve mental health
outcomes up to 3 months
RD0.13
(0.04 to 0.22)
445
(2 trials 1,2)
Low Both studies were con-
sidered high risk of per-
formance bias and one
a high risk of attrit ion
bias
404 per 1000 546 per 1000
(429 to 660)
Improvement in mental
health - from 3 to 12
months
Study population
Consultat ion liaison may lead to lit t le or no
improvement in mental health outcomes between
3 and 12 months
RD0.06
(-0.05 to 0.18)
678
(2 trials 2,3)
Low Both studies were con-
sidered high risk of per-
formance bias and one
a high risk of attrit ion
bias
307 per 1000 438 per 1000
(311 to 574)
Symptoms of mental
disorder - from 3 to 12
months
Consultat ion liaison may lead to lit t le or no dif -
ference in symptoms of mental disorder between
3 and 12 months
SM D -0.15 (-0.32 to 0.
03)
546
(3 trials 4−6)
Low Two of the studies were
considered a high risk
of performance and at-
trit ion bias
Consumer satisfaction
- up to 3 months
Study population
Consultat ion liaison may improve consumer sat-
isfact ion up to 3 months
RD0.31
(0.21 to 0.40)
228
(1 trial 2)
Low This study was consid-
ered a high risk of per-
formance bias4
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640 per 1000 947 per 1000
(879 to 978)
Consumer satisfaction
- from 3 to 12 months
Study population
Consultat ion liaison may also improve, to a lesser
extent, consumer sat isfact ion between 3 and 12
months
RD0.12
(0.06 to 0.19)
445
(2 trials 1,2)
Low Both studies were con-
sidered high risk of per-
formance bias and one
a high risk of attrit ion
bias
731 per 1000 870 per 1000
(802 to 917)
Consumer adherence
to treatment - up to 3
months
Consultat ion liaison may lead to lit t le or no im-
provement in adherence to treatment recommen-
dat ions up to 3 months
RD0.08
(-0.04 to 0.19)
228
(1 trial 2)
Low This study was consid-
ered a high risk of per-
formance bias
Consumer adherence
to treatment - from 3 to
12 months
Study population
Consultat ion liaison may improve adherence to
treatment recommendations between 3 and 12
months
RD0.16
(0.08 to 0.24)
1,251
(7 trials 1,2,5−9)
Moderate Although there were
more studies included
in this analysis, four
were considered a high
risk of performance
bias and four a high risk
of attrit ion bias
463 per 1000 678 per 1000
(575 to 766)
* The basis for the assumed risk (e.g. the median standard care group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval)
is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RD: Risk dif ference
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
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Studies
1. Katon 1995; 2 Katon 1999; 3 Schrader 2005; 4 Datto 2003; 5 Dobscha 2006; 6 Worrall 1999; 7 De Cruppe 2005; 8 Drummond 1990; 9 Katon 1992
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
Description of the condition
Up to 25% of people across the world will be affected by a mental
disorder at some stage in their life. The most prevalent of these
are mood and anxiety disorders which affect 10% and 8% of peo-
ple respectively at any time (WHO 2001). A number of mental
disorders rank among the leading causes of disability, particularly
among 15 to 44 year olds, where depressive disorders are the sec-
ond most common cause of disability-adjusted life years (DALYs),
with schizophrenia 8th and bipolar affective disorder 9th (WHO
2001). In addition, alcohol use disorders and self-inflicted injuries,
both of which are commonly associated with mental disorders, are
ranked as 4th and 5thmost common cause of DALYs amongst this
age group (WHO 2001). Mental disorders account for approxi-
mately 12% of total DALYs lost due to all diseases and illnesses
(Patel 2007;WHO 2001) and increase the risk of ill health, earlier
death, and attempted and completed suicide (Marttunen 2000;
Van Heeringen 2000).
Description of the intervention
Consultation liaison, in its broadest sense, is a model of mental
health care in which there is an interface between mental health
specialists and other health care providers. There is a strong his-
tory of consultation liaison within the hospital setting (Huyse
2000; Ilchef 2006) but the consultation liaison services required
by hospital patients can be quite different from those in primary
care (Ruddy 2005). Hospital patients are more likely to be acutely
physically unwell and more likely to receive short-term interven-
tions compared to patients in primary care (Ruddy 2005).
In more recent years, the potential advantages of consultation li-
aison in the primary care setting have been recognised (Harmon
2000; Sved Williams 2006), and the World Health Organization
(WHO 2001; Kohn 2004) identified primary care as essential to
improving the delivery of mental health care because of its greater
accessibility (Parslow 2000; WHO 2001). Primary care, such as
general or family physician practices, provides general commu-
nity-based health care which links people to specialist services for
specific health needs. In mental health consultation liaison, the
primary care provider maintains a central role in the delivery of
mental health care with the mental health care specialist typically
assessing the person with a mental disorder and providing consul-
tation to the primary care provider (Berardi 2002; Bower 2005;
Ruddy 2005). The mental health specialist may also directly treat
and refer consumers (Berardi 2002; Ruddy 2005). The mental
health specialist is often a psychiatrist, but can also be a men-
tal health nurse, psychologist, social worker, or a team of men-
tal health care providers (Gunn 2009; Kisely 2007; McNamara
2008). Consultation liaison has the potential to improve the abil-
ity of primary care providers to recognise and treat mental disor-
ders (Kisely 2007; Sved-Williams 2010; Younes 2008), enhance
communication between services (Bambling 2007; SvedWilliams
2006), increase effective use of mental health resources (Mitchell
2002; Sved Williams 2006), and decrease mental health admis-
sions (Sved Williams 2006).
Consultation Liaison also lends itself readily to e-health technolo-
gies such as videoconferencing to provide mental health support
in areas with limited access to resources, such as rural areas (Hilty
2006), and in resource-poor settings (Vythilingum 2011).
How the intervention might work
A high proportion of people attending primary care have men-
tal disorders, with estimates of between 20% and 50% (Copty
2005; Hickie 2007; Kisely 2007; Reilly 2012). The most com-
mon disorders in people attending primary care are affective, anx-
iety and somatoform disorders (Bourgeois 2005; Rodrigo 2013;
Sarries 2008). Most people with mental disorders are identified
and treated in primary care settings (Copty 2005; Kessler 2012;
VanRijswijk 2007) andoftenprefer to bemanagedby primary care
professionals (Harmon 2000; Mitchell 2002). However, although
people with mental disorders are more likely to access primary care
than mental health services (Chew-Graham 2007; Sved Williams
2006), many are not correctly diagnosed or do not receive ade-
quate treatment (Hickie 2007; Kohn 2004; Trude 2003), or are di-
agnosed some time after onset (Andrews 2001;Wang 2005). Con-
sultation liaison between primary care providers andmental health
specialists has the potential to improve outcomes for people with a
mental disorder by enhancing the ability of primary care providers
to diagnose and correctly treat mental disorders (Emmanuel 2002;
Gilbody 2003; Kisely 2007; Younes 2008), provide an opportu-
nity for early intervention (Broome 2005; Tovey 2004), and en-
sure that the relationship between the primary care provider and
consumer is not disrupted (Mitchell 2002).
Why it is important to do this review
A previous Cochrane review (Bower 2000) examined the effec-
tiveness of onsite mental health workers in primary care. Due to
increasing research in this area this original review has now been
split into separate reviews on collaborative care and consultation
liaison. TwoCochrane reviews of collaborative care for people with
mental disorders have now been published (Archer 2012; Reilly
2013). No meta-analytic review of consultation liaison services in
primary care settings for people with mental disorders has yet been
published.
O B J E C T I V E S
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To identify whether consultation liaison can have beneficial effects
for people with a mental disorder by improving the ability of
primary care providers to provide mental health care.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Given the findings of the original review by Bower 2000, we be-
lieved that there would be few RCTs in this area and therefore
RCTs, non-randomised controlled trials, controlled before and
after studies, and interrupted time series which met the Effec-
tive Practice and Organisation of Care (EPOC) criteria would
have been included (EPOC2013a).However, all identified studies
which met the inclusion criteria were RCTs. Therefore all future
updates of this review will include RCTs only.
We included both published and unpublished studies and applied
no language restrictions.
Types of participants
1. People with a mental disorder
We included people with a mental disorder presenting to primary
care practices and who the primary care provider regarded as need-
ing mental health care, or had been diagnosed with a mental dis-
order using any diagnostic system, such as the WHO Interna-
tional Classification of Diseases (ICD) or Diagnostic and Statis-
tical Manual (DSM) of Mental Disorders criteria or a scale based
on these criteria. The mental disorder may or may not have been
comorbid with other physical conditions. Consumer participants
could be any age or gender, and could be hospitalised for a mental
disorder during an episode of care.
We excluded studies which focused on people with disorders listed
in the DSM or ICD Mental and Behavioural Disorders which
are considered predominantly physical or behavioural disorders.
Examples include studies of people with an intellectual or learn-
ing disability, Alzheimer’s disease, dementia associated with HIV/
AIDs, for management of overweight or obesity, or nicotine with-
drawal.
2. Primary care providers
We included primary care providers who were healthcare profes-
sionals providing general health care to consumers in need of men-
tal health care. This included general practitioners and physicians
and other health professionals such as nurses.
Types of interventions
Consultation Liaison
We included consultation liaison as a specific service delivery
model, or as a component of a broader service delivery model (for
example, consultation liaison in conjunction with psychoeduca-
tion for consumers).There had to be at least one session where a
mental health specialist consulted with the primary care provider
to be defined as consultation liaison although the amount of con-
tact and method of interaction could vary. Consultation liaison
could include education, problem solving, and formal feedback
from mental health specialists on diagnosis and prescribing or
other strategies designed to enhance the primary care provider’s
management of mental health.There did not have to be direct
contact between the mental health specialist and the consumer.
If there was direct contact, this could be done separately or un-
dertaken jointly with the primary care provider. The amount of
direct care provided to consumers by primary care clinicians and
mental health specialists could vary.
We excluded time-limited educational interventions which fo-
cused on providing generic information about mental disorders
but included consumer-specific educational materials which were
included as part of the consultation liaison process. We also
excluded technology-based mental health interventions such as
screening tools, computerised aids or self-help interventions un-
less the technology was used to support a consultation liaison role.
As it is often difficult to differentiate between collaborative care
and consultation liaison in the literature, we defined collaborative
care as involving at least three types of healthcare professional,
that is the primary care provider, mental health specialist and case
manager (Katon 2001). In contrast, we defined the consultation
liaison model as one where only two types of health professionals
(the primary care provider and mental health specialist) are in-
volved, with the primary care provider maintaining responsibil-
ity for managing care (Katon 2001). The mental health specialist
could differ in terms of speciality, qualifications, training and ex-
perience.
Comparator interventions
• Standard care e.g. primary care care providers continuing to
provide mental health careand referreing to specialist mental
health services where needed
• Other models of mental health care e.g. collaborative care
Types of outcome measures
Primary outcomes
Consumer
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• Improvement in mental health: for example, no longer
meeting diagnostic criteria for a mental disorder or clinical cut-
off score, or a prespecified improvement on a symptom scale for
mental disorders.
• Mental disorder symptoms: scores on validated measures of
mental disorder symptoms.
• Adverse events: any adverse events reported by study
authors.
Secondary outcomes
Consumer
• Relapse: recurrence of mental disorder following
improvement.
• Satisfaction: with treatment.
• Adherence: to prescribed medication or referral to
treatment.
• Disability: scores on a validated disability scale.
• General health status: scores on general health
questionnaires or scales.
• Healthcare visits: visits to either general health or specialist
mental health practitioners or services.
• Number of people lost to follow-up.
Provider
• Diagnosis: number and accuracy of diagnoses of mental
disorders.
• Treatment: number of consumers receiving mental health
treatment and adequacy of treatment.
• Specialist treatment: number and appropriateness of
referrals to, or treatment by, mental health services.
• Prescribing: rate and appropriateness of prescribing
psychotropic medications.
• Adherence: to treatment guidelines or algorithms.
• Knowledge: in diagnosing or treating mental disorders.
• Confidence: in diagnosing or treating mental disorders.
• Cost of treatment.
Search methods for identification of studies
Electronic searches
We searched the following electronic databases for primary studies
in March 2014 .
The EPOCSpecialised Register (and the database of studies await-
ing assessment), using a broad search to capture the range of health
service delivery models relevant to mental health care in general
practice (Appendix 1).
The search terms were:
(psychiatri* or psycho* or mental or depress* or anxiet* or disor-
der* or therap* or counsel*) and (“primary care” or “family practi*”
or “general practi*” or “family medicine” or “family physician*”
or “gp” or “gps”) and (consult* or liais* or refer* or collaborat*))
The Cochrane Central Register of Controlled Trials (CENTRAL)
(The Cochrane Library) (Issue 3, 2014) .(Appendix 1)
Ovid MEDLINE (1946 to March 2014)
Ovid EMBASE (1974 to March 2014)
EBSCO CINAHL (1982 to March 2014)
OVID PsycINFO (1806 to March 2014)
We searched electronic databases using a strategy developed in-
corporating the methodological component of the EPOC search
strategy combined with selected MeSH terms and free text terms
relating to consultation liaison (EPOC 2014) The MEDLINE
search strategywas translated into the other databases using the
appropriate controlled vocabulary as applicable.
The Database of Abstracts of Reviews of Effectiveness (DARE)
was also searched for related reviews.
Searching other resources
We also searched reference lists of studies and relevant reviews to
identify any other potential studies.
Data collection and analysis
Selection of studies
Two review authors independently screened the titles and abstracts
of studies identified from the search for references which appeared
to meet the inclusion criteria. We then compared these potentially
relevant studies and any discrepancies were resolved by discussion.
The full text of all potentially relevant studies were then obtained
and also screened to identify those that met the inclusion criteria
for the review.
Data extraction and management
We developed and piloted a data extraction form for this review
based on theCochrane Effective Practice andOrganisation of Care
(EPOC) Group data collection checklist s(EPOC 2013b). Two
review authors independently extracted methodological and out-
come data from each study independently. Each pair then com-
pared their results. If we identified any differences, they were re-
solved by consensus or referral to a third author. Where further
clarification or missing data were needed from study authors, we
made all reasonable attempts to contact study authors.
We extracted the following information from all included studies.
• Study: the type of study and whether it met the inclusion
criteria.
• Participants
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◦ consumers: number of participants enrolled and lost
to follow-up, age, gender, diagnoses and other mental health or
demographic information.
◦ primary care providers and mental health specialists:
number of participants, age, gender, profession, speciality,
clinical experience and training.
• Intervention: a description of interactions between i)
mental health specialists and consumers, ii) primary care
providers and mental health specialists, and iii) primary care
providers and consumers; as well as the frequency of contacts,
study setting, and length of the intervention.
• Outcomes: consumer and provider outcomes which were
included in the review, how they were defined or measured,
when they were measured, types of data and values.
• Quality criteria - these are described in Assessment of risk of
bias in included studies.
Assessment of risk of bias in included studies
Because all identified studies which met the inclusion criteria were
RCTs they were independently assessed according to the following
risk of bias criteria (Higgins 2011).
Adequate sequence generation (selection bias)
Low risk: a random sequence generationprocess is clearly described
by the study authors; high risk: a non-random sequence generation
process is described; unclear risk: insufficient information
Allocation concealment (selection bias)
Low risk: participants and investigators enrolling participants
could not identify allocation; high risk: participants or investiga-
tors enrolling participants could identify allocation; unclear risk:
insufficient information
Blinding of participants (performance bias)
Low risk: blinding of participants ensured, or incomplete blinding
but the outcome is unlikely to be influenced by lack of blinding;
high risk: no blinding and the outcome is likely to be influenced
by lack of blinding; unclear risk: insufficient information.
Blinding of outcome assessment (detection bias)
Low risk: adequate blinding of outcome assessment is described
or outcome measurement is unlikely to be influenced by lack of
blinding; high risk: no blinding of outcome assessment and mea-
surement likely to be influenced by lack of blinding; unclear risk:
insufficient information
Incomplete outcome data (attrition bias)
Low risk: no missing outcome data or the amount of missing data
is small (up to 5%) and the appropriate imputation methods were
used; high risk: loss to follow-up was more than 25% or more
than 5% if imputation was not used; unclear risk: insufficient
information about attrition or if attrition was between 0% and
5% and imputation was not used or if attrition was between 6 and
25% but appropriate imputation methods were used.
Free of selective reporting (selective reporting)
Low risk: the study protocol is available and all of the study’s pre-
specified outcomes, which are included in the review as primary
outcomes, have been reported; high risk: not all of the study out-
comes, which were primary outcomes in the review, were reported
or data were only reported for a subgroup of participants; unclear
risk: insufficient information or a secondary review outcome was
collected but not reported in a study.
Free of any other bias
Low risk: the study appears to be free of other sources of bias; high
risk: there is at least one important risk of bias such as markedly
different characteristics of participants in each group; unclear risk:
there is insufficient information to assess whether an additional
risk of bias exists, e.g. inadequate description of the demographic
characteristics for each intervention and standard care group.
Two review authors independently extracted risk of bias criteria
data from each study. If there was any disagreement about whether
or not a trial fulfilled a particular risk of bias criterion, these dif-
ferences were resolved by consensus or referral to a third author.
Measures of treatment effect
Binary data
We extracted data from the included studies for the binary out-
comes of improvement in mental health, consumer satisfaction
and adherence, practitioner adherence, diagnosis, treatment, pre-
scribing, and loss to follow-up. For binary outcomes we calculated
the risk difference (RD) and 95% confidence intervals (CIs) using
a a random-effects model. The choice of RD was based on three
criteria (Deeks 2011): i) consistency - there was less heterogene-
ity for RD than than for risk ratio for our data; ii) mathematical
properties - it is used to calculate the NNTB; and iii) ease of in-
terpretation - absolute measures are considered more interpretable
than relative measures.
Continuous data
We extracted data for the continuous outcomes of mental disor-
der symptoms, general health status, disability and healthcare vis-
its from included studies. However, we only included data if the
scale or questionnaire used to measure these outcomes had been
reported as valid and reliable in a peer-reviewed journal. Because a
number of different scales were used for symptoms, we calculated
the standardised mean difference (SMD); however for all other
outcomes which used similar scales or were only reported by indi-
vidual studies, we used the mean difference (MD). If change data
had been reported for the same outcome, these values would have
been included in a meta-analysis using an unstandardised mean
difference. Where SMD was calculated we considered less than
0.40 as a small effect size, 0.40 to 0.70 as moderate, and more
than 0.70 as large (Deeks 2011).
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Skewed data
As a meta-analysis is based on assumptions of normality, we
checked all continuous data for skew before inclusion. For a scale
which starts from zero, a standard deviation which is more than
half the mean suggests skew, while a standard deviation which is
more than the mean is considered strong evidence of a skewed dis-
tribution (Deeks 2011). Therefore, if the standard deviation was
greater than the mean for both groups we did not include these
data in a meta-analysis and reported them separately.
Unit of analysis issues
Wedid not identify any crossover trials. If they had been identified,
only first interval data would have been used as there was a high
likelihood of a carryover effect in the intervention groups.
If corrected data were reported for cluster-randomised trials, we
planned to use these data for meta-analysis. If corrected data were
not reported, we intended to estimate corrections if adequate data
were available; however, these data were also not reported. Also,
we had intended to conduct a sensitivity analysis of these trials on
meta-analytic findings but there was not enough data to be able
to do this.
Dealing with missing data
We used intention-to-treat data and imputed values such as last
observation carried forward values where these were reported. We
had intended to conduct sensitivity analyses to test for any effects
of loss to follow-up on the stability of results but there were not
enough trials reporting primary outcome data for this to be done.
Assessment of heterogeneity
We used a Mantel-Haenszel Chi2 test and the I2 statistic to test
for heterogeneity (Higgins 2003). We considered a Chi2 value of
less than 0.10 or an I2 value of greater than 50%, or both, as
substantial heterogeneity. We conducted a sensitivity analysis to
investigate the potential effects of substantial heterogeneity as well
as investigating possible reasons for this heterogeneity.
Assessment of reporting biases
We had intended that primary outcome data from all included
studies would be entered into a funnel plot (trial effect against
trial size) to investigate the possibility of publication bias; however
there were too few studies reporting primary outcomes to be able
to do this.
Data synthesis
As we collected data for all follow-up periods, we analysed data
as up to and including three months from the start of therapy,
from three to 12 months follow-up, and follow-up for more than
12 months. If more than one set of useable data was reported for
any of these periods (e.g. data at six and nine months follow-up),
because these data could not be pooled, we used the first data set,
as earlier intervals were more likely to have the best rates of follow-
up.
All data were meta-analysed using Review Manager 5.3 (RevMan
2014). We used a random-effects model to synthesise all data as
we considered it unlikely that the same effect was being measured
across studies of such diversity. However, because random-effects
gives more weight to smaller studies than a fixed-effect analysis,
we also compared fixed and random-effects analyses to identify
whether there were any differences (Sensitivity analysis).
Subgroup analysis and investigation of heterogeneity
We had intended to conduct the following subgroup analyses.
• Type of intervention, e.g. consultation liaison only or
consultation liaison within an integrated model.
• Nature of the mental disorder, e.g. types of mental disorder.
• Nature of primary health care setting, e.g. youth-focused
primary health care service versus generalist
• Single versus multiple contacts: between primary care
provider and mental health specialist; and between mental health
specialist and consumer.
However, because of limited data these analyses were not possible.
Sensitivity analysis
Wehad proposed to conduct sensitivity analyses to assess the effect
of risk of selection, performance and detection, attrition and re-
porting but we were unable to do so with the current data because
of the limited number of studies available for meta-analysis. We
were able to compare fixed and random-effects models but there
were no differences except that the 95% confidence interval was
slightly smaller when a fixed-effect model was used.
R E S U L T S
Description of studies
Results of the search
We identified 8191 studies in the database searches, as well as 12
studies from reference lists of other publications. After screening
these 8203 citations we identified 32 studies (48 citations) as po-
tentially relevant and obtained full copies of study publications.
After screening these full texts, we included 12 and excluded 20
studies. See PRISMA study flow diagram (Figure 1).
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Figure 1. PRISMA Study flow diagram.
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Included studies
We included12 studieswith 2605 consumer participants andmore
than 905 primary care providers.
Eleven trials with 2251 consumer participants and more than
838 primary care providers compared consultation liaison to a
standard care group. Five trials randomised consumers to con-
sultation liaison and standard care groups (De Cruppe 2005;
Drummond 1990; Katon 1992; Katon 1995; Katon 1999), four
randomised primary care clinicians (Berti Ceroni 2002; Dobscha
2006; Schrader 2005; Worrall 1999) and two randomised prac-
tices (Datto 2003; Van der Feltz 2006).
One trial with 354 consumer participants and 67 primary care
providers randomised consumers to consultation liaison or collab-
orative care groups (Hedrick 2003).
Six trialswere undertaken in theUSA (Datto 2003;Dobscha 2006;
Hedrick 2003; Katon 1992; Katon 1995; Katon 1999) and one
each in Australia (Schrader 2005), Canada (Worrall 1999), Ger-
many (De Cruppe 2005), Italy (Berti Ceroni 2002), the Nether-
lands (Van der Feltz 2006) and the United Kingdom (Drummond
1990). Apart from Dobscha 2006 and Hedrick 2003 which were
set in Veterans’ Affairs clinics, and Schrader 2005 which enrolled
participants in urban hospitals and delivered consultation liaison
with their GP, all other studies were described as being conducted
in a general practice or primary care setting. The number of sites
involved in each trial ranged fromone (Katon 1995) to 42 (Worrall
1999).
Most trials reported consumer and provider outcomes except
Drummond 1990, Katon 1995, Schrader 2005 and Van der Feltz
2006 which did not compare provider outcomes.
Participants
Consumers
Thenumber of consumer participants included in each trial ranged
from 40 (Drummond 1990) to 669 (Schrader 2005). The average
age of participants was reported in all but two trials (Schrader
2005;Worrall 1999) and ranged from39 to 57 years. Themajority
of consumer participants were female in seven trials (Berti Ceroni
2002; Datto 2003; De Cruppe 2005; Katon 1992; Katon 1995;
Katon 1999; Van der Feltz 2006) and male in four trials, two of
which were set in Veteran’s Affairs clinics (Dobscha 2006; Hedrick
2003) and one aimed at problem drinkers (Drummond 1990).
Gender was not reported in Worrall 1999.
The most common mental health condition for which partici-
pants were included in trials was depression or dysthymia (Berti
Ceroni 2002; Datto 2003; Dobscha 2006; Hedrick 2003; Katon
1995; Katon 1999; Schrader 2005; Worrall 1999). Katon 1992
also included consumers with anxiety or somatoform disorders.
One trial included people with a range of disorders (De Cruppe
2005); one with persistent medically unexplained symptoms (Van
der Feltz 2006), and one included people with problem drinking
(Drummond 1990).
A wide range of consumer exclusion criteria applied across studies.
These included:
• recent (Dobscha 2006; Hedrick 2003) or ongoing (Berti
Ceroni 2002; Hedrick 2003; Katon 1999; Van der Feltz 2006)
mental health treatment ;
• active suicidal ideation/risk or very high depression score,
or both (Datto 2003; Dobscha 2006; Hedrick 2003; Katon
1992; Katon 1995; Van der Feltz 2006);
• having only mild depression (Berti Ceroni 2002);
• psychotic disorder or symptoms (Berti Ceroni 2002;Datto
2003; De Cruppe 2005; Dobscha 2006; Hedrick 2003; Katon
1992; Katon 1995; Katon 1999; Van der Feltz 2006);
• bipolar disorder (Datto 2003; Dobscha 2006;
• dementia (Dobscha 2006; Katon 1992; Katon 1995; Van
der Feltz 2006);
• current alcohol or other substance use problems (Datto
2003; Hedrick 2003; Katon 1992; Katon 1995; Katon 1999;
Van der Feltz 2006);
• requiring treatment for post-traumatic stress disorder
(PTSD) (Hedrick 2003);
• cognitive impairment (Berti Ceroni 2002; Schrader 2005);
• life threatening or terminal illness (Berti Ceroni 2002;De
Cruppe 2005; Dobscha 2006);
• physical impairment (Schrader 2005);
• pregnant or breastfeeding Katon 1999);
• older than 65 (Berti Ceroni 2002) or less than 18 years
(Van der Feltz 2006);
• limited study language (De Cruppe 2005; Katon 1992;
Katon 1995; Katon 1999; Schrader 2005) or being unable to
complete questionnaire (Van der Feltz 2006);
• planning to discontinue health insurance (Katon 1992;
Katon 1995; Katon 1999); and
• being a participant in another trial (Schrader 2005).
Primary care providers
The number of primary care providers was reported in all but two
trials (De Cruppe 2005; Drummond 1990) and ranged from 18
(Katon 1992) to 480 (Schrader 2005). All trials included doctors;
described as general practitioners (GPs) (Berti Ceroni 2002; De
Cruppe 2005; Drummond 1990;Schrader 2005; Van der Feltz
2006), family physicians (Datto 2003; Dobscha 2006; Katon
1992; Katon 1995; Katon 1999;Worrall 1999); internal medicine
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specialists (Datto 2003); residents or internists (Hedrick 2003;
Katon 1992); or fellows (Hedrick 2003). Three trials also included
nurse practitioners (Datto 2003; Dobscha 2006; Hedrick 2003)
and one included physician assistants (Dobscha 2006).
Mental health specialists
Most trials included only one or two mental health specialists
(Berti Ceroni 2002; Datto 2003; Dobscha 2006; Katon 1992;
Katon 1995; Van der Feltz 2006;Worrall 1999), although one trial
involved more than 10 mental health specialists (Hedrick 2003).
Two trials did not report the number of mental health specialists
involved (Katon 1999; Schrader 2005). Themost commonprofes-
sion among mental health specialists was psychiatry, either work-
ing within a single discipline (Berti Ceroni 2002; Katon 1992;
Katon 1995;Katon 1999;Vander Feltz 2006) or cross-disciplinary
team (Datto 2003; Dobscha 2006; Drummond 1990; Hedrick
2003; Schrader 2005; Worrall 1999). One trial involved psycho-
somatic consultants trained in internal medicine and psychother-
apy (De Cruppe 2005). Other mental health specialists working
in teams with psychiatrists included specialist nurses (Datto 2003;
Dobscha 2006; Drummond 1990; Schrader 2005), psychologists
(Hedrick 2003), social workers (Hedrick 2003) and an academic
family physician (Worrall 1999).
Interventions
Consultation liaison
Consultation liaison interventions could involve three levels of
interaction: i) between the mental health specialist and consumer;
ii) between the mental health specialist and primary care provider;
and iii) between the primary care provider and consumer. All trials
except Berti Ceroni 2002 andWorrall 1999 reported on the nature
of interaction between mental health specialists and consumers.
These interactions included:
• assessment interview (Datto 2003; De Cruppe 2005;
Drummond 1990; Katon 1992; Schrader 2005; Van der Feltz
2006);
• referral to specialist mental health care (De Cruppe 2005;
Hedrick 2003; Katon 1995);
• provision of psycho-educational materials such as booklets
and DVDs (Datto 2003; Dobscha 2006; Katon 1995);
• counselling, structured advice or treatment monitoring
(Datto 2003; Dobscha 2006; Drummond 1990; Hedrick 2003;
Katon 1995; Katon 1999); and
• an education session (Dobscha 2006).
Most interactions were face-to-face, but some trials included con-
tact by telephone (Datto 2003; Dobscha 2006; Katon 1999). The
degree of interaction varied from a single session, which was usu-
ally an initial assessment and formulation of a treatment plan (De
Cruppe 2005; Drummond 1990; Katon 1992; Schrader 2005;
Van der Feltz 2006), through to those which included several oc-
casions of contact, either face-to-face or by phone (Datto 2003;
Dobscha 2006; Katon 1995; Katon 1999).
In the case of Hedrick 2003, which compared consultation liaison
to collaborative care, mental health specialists provided treatment
if deemed appropriate in the consultation liaison groups.
All trials reported on the nature of interaction between mental
health specialists and primary care providers, with the nature and
extent of this interaction varying greatly between trials.
The types of interaction reported included:
• meetings to discuss the consumer’s diagnosis, treatment
planning or progress, or both, either face-to-face (Berti Ceroni
2002; Drummond 1990; Katon 1992; Katon 1995; Katon
1999) or by telephone (De Cruppe 2005; Schrader 2005);
• provision of written reports from the mental health
specialist to the primary care provider concerning assessment,
treatment recommendations or progress, or both (Datto 2003;
Dobscha 2006; Hedrick 2003; Katon 1992; Katon 1995;
Schrader 2005; Van der Feltz 2006);
• availability of ongoing consultation advice and support as
needed (Datto 2003; Drummond 1990; Hedrick 2003; Worrall
1999);
• facilitated referral (Dobscha 2006; Hedrick 2003);
• provision of face-to-face professional development training
(Dobscha 2006; Katon 1995; Van der Feltz 2006; Worrall
1999); and
• educational material, such as treatment guidelines
(Drummond 1990; Katon 1992; Schrader 2005).
The amount of contact between mental health specialists and pri-
mary care providers ranged from a single contact (De Cruppe
2005; Schrader 2005), a single contact with the option of fur-
ther contact if required (Datto 2003; Drummond 1990; Hedrick
2003; Katon 1999; Worrall 1999), and between two and 12 con-
tacts with more needed if required (Berti Ceroni 2002; Dobscha
2006; Katon 1992; Katon 1995; Van der Feltz 2006).
Most trials did not specify the type of interaction between the pri-
mary care provider and consumer that occurred in the consultation
liaison intervention (Berti Ceroni 2002; Datto 2003; Dobscha
2006; Drummond 1990; Katon 1992; Katon 1995; Katon 1999;
Schrader 2005; Van der Feltz 2006; Worrall 1999). Of the two
trials which reported the interaction between the primary care
provider and consumer, one stated that the primary care providers
were responsible for initiating treatment and co-ordinating care
(Hedrick 2003) while the other noted that it was recommended to
primary care providers that they specifically discuss the consumer’s
symptoms with the consumer every four to six weeks (De Cruppe
2005).
Collaborative care
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One trial compared consultation liaison with collaborative care
(Hedrick 2003). The collaborative care team included a clini-
cal psychologist, a psychiatrist, social workers and a “psychology
technician”. The mental health team informed the primary care
provider of the consumer’s diagnosis, provided a treatment plan,
and communicated with the primary care provider regarding ad-
herence and progress. Primary care providers were also able to re-
fer to psychologists and social workers working at the clinic. The
social worker or students also provided psychoeducation to con-
sumers and contacted them on a regular basis to encourage adher-
ence, address treatment barriers and assess response. All consumers
received a video and workbook.
Standard care controls
Four studies did not describe what constituted standard care in
detail (Berti Ceroni 2002; Datto 2003; Katon 1992; Schrader
2005).Most studies included assessment of consumers by themen-
tal health specialist (De Cruppe 2005; Drummond 1990), initial
counselling (Drummond 1990), continuing specialist treatment
(Drummond 1990) and referral (DeCruppe2005;Dobscha 2006;
Katon 1995; Katon 1999) or admission (Drummond 1990) to
other services if required. Primary care providers in the standard
care groups also received training in mental health care (Dobscha
2006; Van der Feltz 2006), copies of clinical practice guidelines
(Worrall 1999), and consumer’s symptom scores (Dobscha 2006).
Outcomes
Primary outcomes
Improvement in mental health
Improvement in mental health was defined by a 50% reduction in
the SymptomChecklist (SCL)-90 depression score at four months
in Katon 1995 which compared consultation liaison to standard
care, and at at three and nine months in Hedrick 2003 which
compared consultation liaison to collaborative care. In the other
trials which compared consultation liaison to standard care, im-
provement was defined as asymptomatic (0 to 1 symptoms) on
the nine-symptom Structured Clinical Interview for DSM-IV at
three and six months (Katon 1999); and no longer categorised as
depressed by Centre for Epidemiologic Studies Depression (CES-
D) scores at 12months (Schrader 2005). Other improvement data
were reported which could not be used in a meta-analysis. Im-
provement was defined as remission of diagnosis using the Com-
posite International Diagnostic Interview (CIDI) at 12 months
by Berti Ceroni 2002 but these data were not reported, and Datto
2003 defined improvement by a score of less than 11 on CES-D
scores at 16 weeks, but data were reported as odds ratio.
Symptoms of mental disorder
Depression symptom scores were measured using the Hamilton
Depression Rating Scale (Berti Ceroni 2002), AllgemeineDepres-
sionskala (De Cruppe 2005), the CES-D (Datto 2003; Schrader
2005; Worrall 1999), the SCL-90 (Dobscha 2006; Hedrick 2003;
Katon 1995; Katon 1999; Van der Feltz 2006), and Veterans Short
Form (SF)-36 (Hedrick 2003; Schrader 2005). Depression scores
were measured at one (Dobscha 2006; Katon 1995; Katon 1999;
Van der Feltz 2006), three (Dobscha 2006; Hedrick 2003; Katon
1999), four (Katon 1995), six (De Cruppe 2005; Dobscha 2006;
Katon 1999; Van der Feltz 2006; Worrall 1999), seven (Katon
1995), nine (Dobscha 2006; Hedrick 2003), twelve (Berti Ceroni
2002; Dobscha 2006), and 42 months (De Cruppe 2005). De-
pression scores could not be used from three studies. Data were
reported graphically in Katon 1995 and could not be estimated
because of the resolution of the graph; symptom scores were esti-
mated from graphs in Katon 1999 but data were skewed; and Van
der Feltz 2006 did not report depression scores because ’changes
-- were not significant’.
In Drummond 1990, symptoms were measured using the Alcohol
Problems Questionnaire at six months but data were skewed and
could not be included in a meta-analysis of symptoms.
Adverse events
No adverse events were reported.
Secondary outcomes: consumer
Relapse
Relapse was not reported.
Consumer satisfaction
Consumer satisfaction with treatment was assessed in three stud-
ies comparing consultation liaison to a control: at four months in
Katon 1995; three and six months in Katon 1999, and six and
12 months in Dobscha 2006; and at three and nine months in
Hedrick 2003 which compared consultation liaison to collabora-
tive care. All defined satisfaction as a rating of good or excellent on
a five-point consumer satisfaction rating scale except for Dobscha
2006 which reported mean scores.
Consumer adherence
Consumer adherence was assessed using a wide range of outcomes.
Adherence to treatment was measured at 16 weeks (Datto 2003);
by the use of recommended psychotherapy treatments at six and 42
months (De Cruppe 2005); attending at least three mental health
appointments (Dobscha 2006); filling one or more prescriptions
over 12 months (Katon 1992); obtaining adequate medications
for at least 90 days through automated pharmacy records (Katon
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1995); self-reported adherence to antidepressant therapy for 25 of
the previous 30 days at one, three, and six months (Katon 1999);
and taking antidepressants for six months (Worrall 1999). Ad-
herence in Drummond 1990 was defined as complete abstinence
from alcohol over six months.
Disability scores
Two studies used disability scores. Van der Feltz 2006 used the
Sickness Impact Profile at six weeks and six months, when con-
sultation liaison was compared with treatment as usual. Hedrick
2003 used the Sheehan Disability Scale at three and nine months
when comparing consultation liaison to collaborative care.
General health status
Two studies which compared consultation liaison with treatment
as usual reported general health status; the General Health Ques-
tionnaire at six months was used by Drummond 1990 and the SF-
36 physical health subscale scores at 12 months were reported by
Schrader 2005. Hedrick 2003 also reported SF-36 physical health
scores at three and nine months for consultation liaison and col-
laborative care groups.
Healthcare visits
Six studies reported healthcare visits. Drummond 1990 reported
visits to the GP over six months; Katon 1999 reported visits to
the primary care provider at three and six months; Katon 1995
reported the mean number of healthcare visits over 12 months;
Van der Feltz 2006 reported visits to doctors and other health care
services at six weeks and six months; and Worrall 1999 reported
healthcare visits over six months. However, data fromDrummond
1990; Katon 1999; Van der Feltz 2006; and Worrall 1999 were
skewed and could not be included in a meta-analysis. Dobscha
2006 also reported on the number in each group who attended
more than three primary care appointments over 12 months.
People lost to follow-up
Loss to follow-up per group was reported or could be calcu-
lated from data in Datto 2003; De Cruppe 2005; Dobscha 2006;
Drummond 1990; Katon 1999; Schrader 2005; and Van der Feltz
2006, and were therefore included in a meta-analysis.
Secondary outcomes: provider
Diagnosis
The number of correct diagnoses of depression over six months
per primary care provider group was reported by Worrall 1999.
Received any treatment
One trial reported whether participants in either the consulta-
tion liaison or standard care group received any treatment, includ-
ing pharmacological treatment, psychological treatment (e.g. psy-
chotherapy), or any other treatment (e.g. specialist treatment) at
three to 12 months (Berti Ceroni 2002).
Received adequate treatment
All definitions of adequate treatment were based on the prescrip-
tion of ’adequate’, ’therapeutic’, or ’minimum’ dose of antidepres-
sants. These outcomes were reported when consultation liaison
was compared to standard care by Dobscha 2006; Katon 1995 and
Katon 1999 and to collaborative care by Hedrick 2003. Across
these studies adequate treatment was reported for several time in-
tervals but because all these studies reported adequate treatment
for 90 days, these data were used for meta-analysis.
Specialist treatment
Specialist treatment was defined by seeing psychotherapists over
12 months (Berti Ceroni 2002) and referrals to mental health
professionals over six months (Worrall 1999). Hedrick 2003 also
reported the number of people receiving cognitive behavioural
therapy but as this was only available to the collaborative care
group it was not included.
Prescribing
Worrall 1999 reported whether pharmacological treatment was
prescribed at the first visit to the primary care provider; three
studies reported on whether it was prescribed over 12 months
((Berti Ceroni 2002; Dobscha 2006; Katon 1992); and one over
more than 12 months (De Cruppe 2005). Hedrick 2003 reported
prescribing over the nine months of the trial.
Primary Care Provider adherence
Provider adherence was assessed in Datto 2003 by asking con-
sumers whether primary care providers had made treatment rec-
ommendations up to 12weeks and inDe Cruppe 2005 bywhether
GPs had followed through with consultation liaison recommen-
dations at six months.
Knowledge
No measures of improving knowledge in diagnosing or treating
mental disorders were reported.
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Confidence
No measures of confidence in diagnosing or treating mental dis-
orders were reported.
Cost
Total cost per person in the collaborative care and consultation
liaison groups over nine months was reported by Hedrick 2003.
Excluded studies
Twenty studies were excluded, six were studies of collaborative
care (Bauer 2011; Bogner 2012; Dietrich 2004; Horner 2005;
Llewellyn-Jones 1999; Serrano 2011); five were implementation
studies of another quality improvement intervention (Arora 2011;
Baker 2001; Chung 2011; Sinnema 2011; Tello-Bernabe 2011);
and three were controlled before and after studies that did notmeet
the EPOC inclusion criteria (Carr 1997; Harvey 2012; Wiener
2006). In addition, the decision for treatment to be delivered by
primary care providers, the consultant psychiatrist, community
mental health centre, or a combination of these was based on a
treatment algorithm in Menchetti 2007; Liu 2007 was set in a
hospital general medical outpatient clinic; consumer participants
in Stiefel 2008 did not necessarily have a mental disorder; Su 2011
was an audit of a hospital consultation liaison service; Sherbourne
2001 was a trial of treatment recommendations; and inWells 1999
the interaction between the mental health specialist and primary
care provider was focused on education only.
Risk of bias in included studies
Selection bias due to random sequence generation was rated as low
in six studies and unclear in the remaining six. The potential for
selection bias due to allocation concealment was rated unclear in
11 studies and low in one study. Eight studies were considered a
high risk of performance bias with only one trial rated low and the
remainder rated unclear. Eight studies were also rated a high risk
of attrition bias, with two rated as low, and two unclear. Six studies
were considered a high risk of attrition bias with the reminder
rated as unclear. Six were also rated as a high risk of reporting bias
with none rated as low. Three studies were rated a high risk of
other potential biases, seven as unclear and two as a low risk of
other bias. See ’Risk of bias’ summary Figure 2 and details below.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Six trials (De Cruppe 2005; Dobscha 2006; Katon 1995; Katon
1999; Schrader 2005; Worrall 1999) described how the randomi-
sation sequence was generated, so we rated these a low risk of bias,
the remainder did not describe how the randomisation sequence
was generated and we therefore rated these an unclear risk. Alloca-
tion concealment was only described by De Cruppe 2005 which
we therefore rated as a low risk. All other trials did not describe
allocation concealment and were therefore rated unclear.
Blinding
Although a number of trials referred to blinded assessment of out-
comes (De Cruppe 2005; Dobscha 2006; Hedrick 2003; Katon
1992; Katon 1995; Katon 1999; Van der Feltz 2006), the mea-
sures that were used were self-reported. Therefore in all trials, if
consumers were likely to be aware whether they were receiving
specialist treatment, we rated them a high risk of performance bias
(Datto 2003; Dobscha 2006; Hedrick 2003; Katon 1992; Katon
1995; Katon 1999; Schrader 2005; Van der Feltz 2006).
We considered Drummond 1990 a low risk of performance bias
because the interaction between participants and specialists were
similar in both groups. We rated the remaining trials as an unclear
risk because participants probably did not know if they were in
the active group (Berti Ceroni 2002; De Cruppe 2005; Worrall
1999)
Incomplete outcome data
As there was no loss to follow-up in Katon 1992 and Van der Feltz
2006 they were rated a low risk of attrition bias. Worrall 1999 was
rated as unclear because the loss to follow-up was not reported
and while Katon 1999 reported using imputed data in analyses
because the loss to follow-up was more than 5% it was also rated
an unclear risk. All other trials were rated a high risk of attrition
bias because the loss to follow-up was more than 5%.
Selective reporting
Werated six trials as havinghigh risk of reporting bias: Berti Ceroni
2002 did not report any of the consumer outcomes by group;
Datto 2003 only reported categorical outcomes for a subsample
who hadmajor depression at baseline; the only consumer outcome
reported by De Cruppe 2005 was the use of psychotherapies;
Schrader 2005 did not report SF-36 mental health scores; Van
der Feltz 2006; did not report SCL-R-90 results as they were not
significant; and Worrall 1999 did not report the results for the
SCL-90-R even though this was a primary outcome.
The remaining trials were rated an unclear risk of reporting bias
because although all primary outcomes appear to have been re-
ported there was no protocol available to check.
Other potential sources of bias
We rated three trials a high risk of other potential biases. Datto
2003 because significantly more consumers in the standard care
group were prescribed antidepressants at baseline (74% versus
37%) and there were more women in the intervention group
(67% versus 55%). Other trials were rated as an unclear risk: Berti
Ceroni 2002 because there were more consumers with severe de-
pression allocated to the standard care group (nine versus six6); in
Dobscha 2006, more participants in the standard care group had
PTSD (44% versus 35%); there were differences between groups
in age, time in present accommodation and time until follow-
up in Drummond 1990; in Hedrick 2003, the collaborative care
group was more likely to have previous depression (59.5% versus
48.4%) and major depression (65% versus 55%); in Katon 1995
there were relatively little data to compare groups on baseline char-
acteristics, but there seemed to be more females in the standard
care group; and in Katon 1999, there were more females in the
standard care group (82% versus 68%). In addition, of the six clus-
ter randomised trials (Berti Ceroni 2002; Datto 2003; Dobscha
2006; Schrader 2005; Van der Feltz 2006; Worrall 1999), three
(includingBerti Ceroni 2002 andWorrall 1999which randomised
clinicians and Datto 2003 which randomised practices), did not
appear to account for clustering in the reporting of data and are
therefore at risk of unit of analysis error.
We did not identify any other potential sources of bias in De
Cruppe 2005, Katon 1992 or Schrader 2005.
Unit of analysis errors
There were potential unit of analysis errors in several trials. For
trials which compared consultation liaison to a control, there ap-
peared to be unit of analysis errors in three trials reporting con-
sumer outcomes because they were randomised by provider (Berti
Ceroni 2002; Worrall 1999) or practice (Datto 2003). Another
three trials reporting consumer outcomes were also randomised
by provider (Dobscha 2006; Schrader 2005) or practice (Van der
Feltz 2006) but this was allowed for in the analysis of data. There
were also apparent unit of analysis errors for two trials reporting
provider outcomes for consultation liaison versus standard care
because they were randomised by consumer (De Cruppe 2005)
and by practice (Datto 2003). Katon 1992 and Katon 1999 also
randomised by consumer and reported the provider outcomes of
prescribing and adequate treatment; however the correct sample
size for these was consumers. Although corrections for the ran-
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domisation of consumers were done inHedrick 2003, which com-
pared consultation liaison to collaborative care, provider outcomes
were prone to unit of analysis bias because corrected data were not
reported.
Effects of interventions
See: Summary of findings for the main comparison
Consultation liaison versus standard care for people with mental
disorders
Comparison 1: Consultation liaison versus controls
Primary consumer outcomes
Improvement in mental health
More people had improved in the consultation liaison group com-
pared to the standard care group up to three monthsfollowing the
start of treatment (two trials, n = 445, RD 0.13, 95% CI 0.04 to
0.22; NNTB 8, 95% CI 5 to 25, I2 = 14% Analysis 1.1) but not
from three to 12 months, although there was substantial hetero-
geneity between these two studies (two trials, n = 678, RD 0.06,
95% CI -0.05 to 0.18, I2 = 57% Analysis 1.1). There were no
apparent reasons for the heterogeneity between these studies. Im-
provement after 12 months was not reported.
Mental disorder symptoms
There was little or no difference in symptoms from three to 12
months between the consultation liaison and standard care groups
(three trials, n = 546, SMD -0.15, 95%CI -0.32 to -0.03, I2 = 3%,
Analysis 1.2). Katon 1999 also reported depression symptoms at
one, three and six months, andDrummond 1990 reported alcohol
problems at six months. However, these data were skewed and
were therefore not included in the meta-analysis (see Table 1). No
trials reported symptoms after 12 months.
Secondary consumer outcomes
Consumer satisfaction
People in the consultation liaison group were more likely to be
satisfied with treatment up to three months following the start of
treatment (one trial, n = 228, RD 0.31, 95% CI 0.21 to 0.40;
NNTB 3, 95% CI 2 to 5, Analysis 1.3) and from three to 12
months following therapy (two trials, n = 445, RD 0.12, 95%
CI 0.06 to 0.19, I2 = 0%; NNTB 8, 95% CI 5 to 17, Analysis
1.3). Satisfaction was not reported after 12 months. Dobscha
2006 also reported greater satisfactionwith care in the consultation
liaison group but this was reported as mean scores with no variance
(consultation liaison mean: 3.58, standard care mean: 1.16).
Consumer adherence
People in the consultation liaison group weremore likely to adhere
to treatment recommendations from three to12 months (seven
trials, n = 1251, RD 0.16, 95%CI 0.08 to 0.24, I2 = 57%; NNTB
6, 95% CI 4 to 13, Analysis 1.4) but not up to three months (one
trial, n = 228, RD 0.08, 95% CI -0.04 to 0.19, Analysis 1.4) or
after 12months (one trial, n = 53, RD0.03, 95%CI -0.22 to 0.27,
Analysis 1.4). In sensitivity analysis, the substantial heterogeneity
at three to 12 months of 57% was reduced to 0% by removing
data fromKaton 1995 with little difference in risk (RD 0.12, 95%
CI 0.06 to 0.17). A possible explanation for the markedly greater
improvement in the consultation liaison group compared to other
studies was because all participants in this study had agreed to
antidepressant therapy.
Disability
Disability scores were lower in the consultation liaison group at
six weeks (n = 81, MD -14.10, 95% CI -24.32 to -3.88, Analysis
1.5) and six months (n = 81, MD -16.00, 95% CI -25.56 to -
6.44, Analysis 1.5) in the one trial which compared this outcome
in consultation liaison and standard care groups.
General health status
Drummond 1990 reported data for general health status but as
data were skewed (consultation liaison: n = 18, mean 5.6, SD
6.4; control: n = 18, mean 5.2, SD 8.3) they were not included
in a meta-analysis. Schrader 2005 reported health scores of 36.7
and 37.6 in the consultation liaison and standard care groups
respectively but did not report variance.
Healthcare visits
There was little or no difference in the number of healthcare visits
over 12months reported by Katon 1995 (n = 217, MD 0.80, 95%
CI -0.03 to 1.63, Analysis 1.6). Drummond 1990, Katon 1999;
Van der Feltz 2006 and Worrall 1999 also reported healthcare
visits but as data were skewed, they were not included in a meta-
analysis (see Table 2). Dobscha 2006 also reportedmore than three
visits to the primary care provider (consultation liaison: 39.2%;
standard care mean: 49.1%)
People lost to follow-up
There was little or no difference between consultation liaison and
standard care groups in people lost to follow-up at three months
(one trial, n = 84, RD = -0.05, 95% CI -0.19 to 0.09, Analysis
1.7), from three to six months (seven trials, n = 1544, RD 0.00,
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95% CI -0.03 to 0.04, I2 = 0%, Analysis 1.7) or more than 12
months after treatment (one trial, n = 67, RD 0.10, 95% CI -0.12
to 0.31, Analysis 1.7).
Provider outcomes
Diagnosis
There was little or no difference in correct diagnosis rates over six
months in the one trial that reported this outcome (n = 137, RD
-0.02, 95% CI -0.10 to 0.06, Analysis 1.8).
Received any treatment
There was little or no difference between groups in the one trial
which reported participants who received any type of mental
health treatment from three to 12months (n = 80, RD -0.09, 95%
CI -0.31 to 0.13, Analysis 1.9).
Received adequate treatment
Participants in the consultation liaison group were more likely to
receive adequate treatment between three and 12 months (three
trials, n = 797, RD 0.15, 95% CI 0.06 to 0.24; NNTB 7, 95%
CI 4 to 17, I2 = 53%, Analysis 1.10). No studies reported this
outcome for other intervals. In a sensitivity analysis the substantial
heterogeneity was reduced to 0% by removing Katon 1999 from
the analysis with little change in estimates (RD 0.11, 95%CI 0.04
to 0.17) but there was no apparent reason for this heterogeneity.
Specialist treatment
There was little or no difference in specialist mental health care
from three to 12months (n = 227, RD 0.05, 95%CI -0.10 to 0.20
Analysis 1.11) although there was a very high level of heterogeneity
between the two studies reporting these data (I2 = 77%).
Prescribing
People in the consultation liaison group were more likely to be
prescribed pharmacological treatment for a mental disorder than
people in the standard care group between three and 12 months
(four trials, n = 796, RD 0.08, 95% CI 0.02 to 0.15; NNTB 13,
95% CI 7 to 50, I2 = 17%, Analysis 1.12), but not in the one trial
that reported prescribing after 12 months (n = 48, RD 0.02, 95%
CI -0.25 to 0.30, Analysis 1.12).
Primary Care Provider adherence
There was little or no difference in provider adherence from three
to 12 months in the one trial which reported this outcome (n =
53, RD 0.18, 95% CI -0.08 to 0.43, Analysis 1.13). Datto 2003
also reported adherence but as an odds ratio which could not be
added to the meta-analysis (OR 3.30 95% CI 0.88 to 12.36).
Comparison 2: Consultation liaison versus
collaborative care
Only one trial (Hedrick 2003) compared consultation liaison with
collaborative care.
Primary outcomes: consumer
Improvement in mental health
There was little or no difference between the consultation liaison
and collaborative care groups in the number of consumers who
had improved at three months (n = 328, RD -0.02, 95% CI -0.10
to 0.06, Analysis 2.1) or nine months (n = 326, RD -0.03, 95%
CI -0.11 to 0.05, Analysis 2.1).
Mental disorder symptoms
Symptom scores were better in the collaborative care group at
three months (n = 328, MD 0.20, 95% CI 0.06 to 0.34, Analysis
2.2) and nine months (n = 326, MD 0.16, 95% CI 0.01 to 0.31,
Analysis 2.2).
Secondary outcomes: consumer
Consumer satisfaction
There was little or no difference in consumer satisfaction at three
(n = 328, RD -0.02, 95% CI -0.09 to 0.06, Analysis 2.3) or nine
months (n = 326, RD 0.00, 95% CI -0.07 to 0.08, Analysis 2.3).
Disability
Disability scores were lower in the collaborative care group at three
(n = 328, MD 0.72, 95% CI 0.18 to 1.26, Analysis 2.4) and nine
months (n = 326, MD 0.60, 95% CI 0.03 to 1.17, Analysis 2.4).
General health status
General health scores were lower in the consultation liaison group
at three (n = 328, MD -3.35, 95% CI -5.91 to -0.79, Analysis 2.5)
and nine months (n = 326, MD -3.49, 95% CI -6.28 to -0.70,
Analysis 2.5).
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Healthcare visits
Themean number of healthcare visits were reported (consultation
liaison 8.9; collaborative care 8.5) but because variance was not
reported and the sample number was unclear, these data could not
be included in a meta-analysis.
People lost to follow-up
There was little or no difference in loss to follow-up at three (n
= 342, RD -0.00, 95% CI -0.06 to 0.05, Analysis 2.6) or nine
months (n = 342, RD -0.05, 95% CI -0.11 to 0.01, Analysis 2.6).
Secondary outcomes: provider
Received adequate treatment
People in the consultation liaison group were less likely to receive
adequate treatment up to nine months (n = 326, RD -0.17, 95%
CI -0.27 to -0.06; NNTB 6, 95% CI 4 to 17 Analysis 2.7).
Prescribing
People in the consultation liaison group were less likely to receive
pharmacological treatment up to nine months (n = 326, RD -
0.18, 95% CI -0.27 to -0.08; NNB 6, 95% CI 4 to 13 Analysis
2.8).
Cost
The mean cost for each group was reported (consultation liaison:
6789 US Dollars, n = 186; collaborative care: 7946 US Dollars, n
= 168). Variance was not reported and so this outcome could not
be added to a meta-analytic graph.
Publication Bias
There was not enough data to investigate potential publication
bias.
D I S C U S S I O N
Summary of main results
The review found that people with a mental disorder were more
likely to improve for up to three months when a consultation li-
aison model was used, compared to standard care. A consultation
liaison model also increased consumer satisfaction and adherence.
Consultation liaison also appeared to improve the prescription of
pharmacological treatment by primary care providers, compared
to standard care. However, the quality of these findings were low
for all outcomes apart from consumer adherence which was of
moderate quality (Summary of findings for the main comparison)
There was also some evidence from one trial that the consulta-
tion liaison model may not be as effective as a collaborative care
with regard to mental disorder symptoms, general health status,
disability, and provision of treatment.
Overall completeness and applicability of
evidence
Generalisability of the review findings to all people with mental
disorders is limited by the types of participants included in these
trials. All primary outcome data came from participants with de-
pressive disorders. Therefore no conclusions can be made regard-
ing the use of consultation liaison with people who have other
mental disorders, particularly disorders such as schizophrenia or
bipolar disorder. There were also no datawhich could inform prac-
tice with specific groups of people such as children and adolescents
or the elderly.
The measures of treatment adequacy were based on the prescrip-
tion of antidepressants therefore no conclusions canbe drawn from
this review regarding the use of treatments other than medication
for depression.
The length of follow-up in the included trials was generally good
with a minimum four months follow-up in one trial and follow-
up of 12 months or more in five trials.
Healthcare providers working in, and consumers presenting to
general hospital settings were excluded as they represent different
populations of healthcare providers and consumers. Therefore,
consultation liaison within the hospital setting would be suited to
a separate review.
Quality of the evidence
Despite having thought there would be few, if any RCTs in this
area, it was a positive sign that all included trials were RCTs.
However, as therewas considerable risk of bias in the included trials
the quality of evidence was considered low formost outcomes. The
difficulty in blinding participants was a particular risk of bias with
most of the included trials as most outcomes were self reported.
Eight trials were rated as a high risk of performance and detection
bias with only one rated as a low risk. Bias due to attrition is also of
concern with an overall loss to follow-up of 10% at three months
to nearly 20% at 12 months or more; eight trials were considered
a high risk of attrition bias with two rated as low risk. Selective
reporting of data was also a potential bias as six trials were rated a
high risk of reporting bias and none as low risk. We were unable
to investigate the possibility of publication bias because of a lack
of data.
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In addition, the quality of the evidence is limited by the relatively
low number of studies and participants contributing data to any
one outcome. When consultation liaison was compared to a con-
trol, most outcome data came from one to three trials with 53 to
797 participants. Exceptions were adherence and loss to follow-up
where data came from seven trials with up to 1544 participants,
and prescribing where data came from four trials with 796 par-
ticipants. All data comparing consultation liaison to collaborative
care came from only one trial with 328 participants.
Potential biases in the review process
Considerable efforts were made to avoid potential biases in search-
ing for relevant studies, selecting studies, extracting and analysing
data, and reporting the review findings. The search covered a wide
range of databases and yielded a high number of studies. In addi-
tion, reference lists of identified studies and reviews were checked.
However, given the large number of identified studies (8191) and
differing terminology used to describe consultation liaison, it is
possible some studies may have been missed.
Apart from one set of consumer outcomes, data for all included
outcomes appear to have been reported but because no protocols
were identified for these studies, it is possible that other relevant
outcomes may have been collected but not reported.
It is also possible that we were more likely to identify studies
which reported positive findings for consultation liaison but be-
cause there were too few studies reporting a single primary out-
come, we were not able to investigate the possibility of publication
bias.
Agreements and disagreements with other
studies or reviews
To date there has not been a systematic review of the effects of
primary care consultation liaison on outcomes for people with
mental disorders. However, there has been a meta-analysis of the
effectiveness of consultation liaison specifically in people with de-
pression (Cape 2010) and one meta-analysis of psychiatric con-
sultation models in primary care (Van der Feltz-Cornelis 2010).
Although the definition of consultation liaison patients used by
Cape 2010 (patients seen once or twice by a mental health spe-
cialist and advice about management to a GP, but with no treat-
ment actually provided by the mental health professional) differed
from the definition we used, four of the five studies included by
Cape 2010 were also included in our review. As with our findings,
Cape 2010 reported no change in depression symptoms, although
we did find an improvement in mental health with consultation
liaison. Unlike our review; however, they found no difference in
antidepressant use while we found an improvement in prescribing
and consumer adherence. This lack of an effect of consultation
liaison in Cape 2010 may have been due to the smaller number of
studies. Four of the studies in our review were also included in the
ten studies included by Van der Feltz-Cornelis 2010, which com-
pared collaborative care and consultation liaison to care as usual.
This review found a moderate improvement in a single meta-anal-
ysis including both collaborative care and consultation liaison, and
pooling data across a range of outcomes including symptom re-
duction, function, treatment adherence, general health, healthcare
use and cost (Van der Feltz-Cornelis 2010).
As there are no formally recognised definitions of primary care-
based mental health care, five of the 12 studies included in our
review were also identified in the 79 studies included in the re-
view of Collaborative care for depression and anxiety problems by
Archer 2012. This review defined Collaborative Care as a multi-
professional approach, structured management plan, scheduled
patient follow-up, and enhanced inter-professional communica-
tion (Archer 2012). As with our review, Archer 2012 found a
significant improvement in people’s symptoms, medication usage
and satisfaction.
Our findings are also similar to the Cochrane review by Bower
2000 which found that onsite mental health workers improved
the prescribing behaviour of primary care providers.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The review found that consultation liaison improvesmental health
outcomes for consumers, particularly those with depression, for
up to three months and improves consumer satisfaction and ad-
herence up to 12 months. Primary care providers were also more
likely to provide adequate treatment and prescribe pharmacologi-
cal therapy for up to 12 months. There was also limited evidence
that the consultation liaison model may not be as effective as
collaborative care in terms of mental disorder symptoms, general
health status, lower disability, and provision of treatment. More
evidence is needed to determine the effectiveness of consultation
liaison for people with mental disorders other than depression.
Implications for research
Given the limitations of the available evidence there is a consider-
able need for further RCTs of consultation liaison in the primary
care setting. There is also a need formore trials comparing different
models of deliveringmental healthcare in the primary care setting.
Future trials should take particular care to address potential biases,
particularly the blinding of participants. It is also important that
trials address the CONSORT criteria for RCTs (Moher 2001).
None of the identified trials included participants with schizophre-
nia or bipolar disorder, therefore trials which include people who
may have quite different mental health care needs to people with
depression are needed. Also, given the differing mental health
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needs of adolescent and older people, trials reporting separate data
for these age groups are required.
Given the wide range of elements, frequency andmodes of contact
between consumers and providers in the consultation liaisonmod-
els used in these trials, studies of a more standardised yet feasible
model are to be encouraged. Also, given the difficulty in differen-
tiating primary care-based models of mental health care, broader
efforts to agree and formally recognise definitions should be made.
Future trials need to measure the consumer outcomes of improve-
ment in mental health and mental disorder symptoms. Other out-
comes such as general health, quality of life, satisfaction and ad-
verse events should also be reported. With regard to provider out-
comes, satisfaction, cost, and the adequacy of treatment, including
non-pharmacological treatments, should be reported. In addition,
validated scales and measures should be used for all outcomes. So
that these trials can be added to meta-analytic updates, all data
should be reported or made available and use the most commonly
identified measures in this review. In particular, separate data for
specific types of mental disorders and different age groups (i.e.
children and adolescents and the elderly) should be made avail-
able.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Berti Ceroni 2002
Methods Cluster-randomised controlled trial of consultation liaison compared to standard care
Participants Consumers (n = 92): People attending primary care practices diagnosed by Composite
International Diagnostic Interview (CIDI) for DSM-IV major depression, minor de-
pression (at least three major depression symptoms including anhedonia or depressed
mood) or subsyndromal depression (at least two symptoms excluding anhedonia and
depressed mood). Their mean age was 44.6 years, 80% were female (n = 64). Major
depression 15, minor 38 and subsyndromal 27
Excluded: Older than 65 years, life-threatening illness, psychotic disorders, cognitive
impairment or ongoing treatment with a mental health specialist
Primary care providers (n = 30): GPs with an established practice of at least ten years.
Mental health specialists (n = 2): one psychiatrist from a local community mental health
service and one experienced in primary care psychiatry
Setting: general health care settings in rural and urban areas, Bologna, Italy
Interventions 1. Consultation Liaison (n = 44).
Mental health specialist/consumer: interaction not reported.
Mental health specialist/primary care provider:primary care providers and two psychiatrists
met in 12 biweekly groups of two hours where diagnoses and planning for therapies were
discussed. Each consumer was discussed at least three times
Primary care provider/consumer: interaction not reported.
2. Standard care (n = 36).
Treatment as usual although the primary care provider received feedback on diagnosis
Outcomes 1. Consumer
Improvement: remission of diagnosis (CIDI) at 12 months.
Symptoms: Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, Medical
Outcomes Study Short Form - 36 at 12 months
General Health: General Health Questionnaire (GHQ-12) at 3 and 12 months.
2. Provider
Treatment: received any treatment over 12 months.
Prescribing: received pharmacotherapy over 12 months.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Primary care providers were block ran-
domised but how this was done was not
described
Allocation concealment (selection bias) Unclear risk Not reported.
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Berti Ceroni 2002 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Primary care providers would have been
aware which groups they were in so this
may have affected treatment patterns. It is
not clear whether consumers would have
been aware if they were in the active group
Incomplete outcome data (attrition bias)
All outcomes
High risk Data was only reported for those available
at 12 months follow-up, loss to follow-up
13%
Selective reporting (reporting bias) High risk None of the consumer outcomes were re-
ported by group.
Other bias Unclear risk There weremore consumers with severe de-
pression in the standard care group (9 vs
6) at baseline. Cluster randomisation does
not seem to have been accounted for in the
analysis
Datto 2003
Methods Cluster-randomised controlled trial of telephone disease management compared to stan-
dard care
Participants Consumers (n = 84): Primary care consumers with symptoms suggestive of depression
who agreed to be monitored by telephone. The mean age was 46.9 years, 60.8% female,
80% white. The mean score on the Centre for Epidemiological Studies Depression Scale
(CES-D) was 32.2; 84.8% were diagnosed with major depression, 55.5% prescribed
antidepressants and 16.5% referred for mental health treatment
Excluded: Significant suicide risk, current substance abuse problems, psychotic symp-
toms, bipolar affective disorder
Primary care providers (n = 74): primary care providers working at study practices, 46
internal medicine and 24 family practice doctors, and 4 nurse practitioners
Mental health specialists (n = 1): one nurse who was trained and experienced in mental
health and received weekly supervision from a health system psychiatrist
Setting: 35 primary care practices, 13 urban and 22 suburban.
Interventions 1. Telephone Disease Management (n = 42)
Mental health specialist/Consumer: follow up telephone assessments and education every
three weeks. Topics included depression as a treatable condition, treatment options and
side effects, coping skills, risk factors, suicide prevention and reinforcing follow-up with
primary care provider. Hard copy educational material was also provided
Mental health specialist/primary care provider: primary care provider provided with writ-
ten individual consumer feedback after each assessment, including depression scores
and clinical interpretation. General treatment recommendations were provided, with
reference to a depression treatment algorithm based on AHRQ guidelines. Also asked
clinician about depressive symptomatology, diagnostic criteria, and need for treatment
modifications. Contact with psychiatrist also available if necessary
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Datto 2003 (Continued)
Primary care provider/consumer: interaction not reported.
2. Standard care (n = 42).
Assessed at 16 weeks.
Outcomes 1. Consumer
Improvement: remitted depression defined by a CES-D < 11 at 16 weeks.
Symptoms: CES-D (20 item); Medical Outcomes Study Short Form -12 at 16 weeks
2. Primary care provider
Adherence: asked consumers whether primary care providers had made treatment recom-
mendations over 12 weeks
Notes Improvement and provider adherence were reported as odds ratios for a subsample of
participants
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomised by primary care practice.
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
All outcomes
High risk Probable that participants knew they were
in an active group
Incomplete outcome data (attrition bias)
All outcomes
High risk Data was reported for those available at fol-
low-up, loss to follow-up 14%
Selective reporting (reporting bias) High risk All categorical outcomes were only re-
ported for a subsample who had major de-
pression at baseline
Other bias High risk Significantly more consumers in the stan-
dard care group were prescribed antide-
pressants at baseline (74% vs 37%) and
there weremore women in the intervention
group (67% vs 55%). Cluster randomisa-
tion does not seem to have been accounted
for in the analysis
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De Cruppe 2005
Methods Randomised controlled trial of consultation liaison compared to standard care
Participants Consumers (n = 67): consumers referred to a hospital-based psychosomatic consultation
liaison service. Their mean age was 45 years, 42% were male. Somatoform disorders 21,
common psychiatric disorders 22, and adjustment disorder or stress reaction 24
Excluded: organic mental disorders; substance- and abuse-related disorders, schizophre-
nia, schizotypal or delusional disorders, pre-terminal illness or limited German
Primary care providers (n not reported): general practitioners of a consumer randomised
to the intervention group, 62.4% had received certification for psychosomatic primary
care
Mental health specialists (n = 5): psychosomatic consultants trained in internal medicine
and psychotherapy with one year training
Setting: GP practices in Germany 1998-9.
Interventions 1. Consultation Liaison (n = 33)
Mental health specialist/consumer: initial assessment through hospital psychosomatic con-
sultation liaison service and recommendation for further psychosocial care and therapy
Mental health specialist/primary care provider: one phone-call (10 min) and one written
report. Both incorporated diagnosis, symptom-related psychosocial findings and therapy
recommendations
Primary care provider/consumer: recommendations were made to primary care providers
to hold symptom-based conversations with the client integrating psychosocial aspects
every four to six weeks
2. Standard care (n = 34)
Mental health specialist/consumer: initial assessment through hospital psychosomatic con-
sultation liaison service and recommendation for further psychosocial care and therapy
(as for consultation liaison)
Outcomes 1. Consumer
Symptoms: Beschwerden Liste (general and somatic symptoms, 24 item), Allgemeine
Depressionskala (Depressive symptoms, 20 item), State-Trait Anxiety Inventory (20
item), WHO Global Assessment of Social Functioning (five-point scale) at 6 and 42
months
Adherence: used recommended psychotherapy treatments at 6 and 42 months
2. Provider
Adherence: followed through with CL recommendations over 6 months.
Notes As provider sample sizes were not reported, these were assumed to be the same as con-
sumers for provider adherence
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk An independent statistician block ran-
domised consumers by diagnosis
Allocation concealment (selection bias) Low risk See sequence generation.
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Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Independent statistician was responsible
for psychometric tests but responses were
self-reported; however, participants proba-
bly did not know whether they were in the
active group
Incomplete outcome data (attrition bias)
All outcomes
High risk Data was reported for those available at fol-
low-up, loss to follow-up at 6months 21%,
42 months 28%
Selective reporting (reporting bias) High risk The only consumer outcome reported
was use of psychotherapies. Primary care
provider adherence was reported but sam-
ple sizes were not reported
Other bias Unclear risk No other bias identified.
Dobscha 2006
Methods Cluster-randomised trial of a decision support intervention compared to standard care
Participants Consumers (n = 375): consumers of participating clinicians with Patient Health Ques-
tionnaire (PHQ)-9 depression scores of 10 to 25 at screening and between 10 to 20 or a
score of at least 1 on the Hopkins Symptom checklist (SCL-20) at enrolment. Major de-
pression 49%, dysthymia 47%, moderate-great pain 68%, alcohol disorder 17%, panic
disorder 14%, other anxiety disorder 25%, PTSD 39%, taking antidepressant at study
entry 41%. Their mean age 56.8 years, 349 were male; white 177, non-white 10, not
recorded 188
Excluded: received specialist mental health treatment in previous six months, dementia,
psychotic or bipolar disorder terminal illness, and people referred for urgent care because
of PHQ-9 scores of 25 or more and/or active dangerous ideation
Primary care providers (n = 41): full and part time physicians (28), physician assistants
or nurse practitioners (13). Mean age 45.1 years; female 21. Mean time since training
15.1 years
Mental health specialists (n = 2): One psychiatrist 4 hours per week and one nurse care
manager 8 hours per week in the intervention group. An on-site mental health consul-
tation team was also available to both groups
Setting: five Veterans Affairs medical clinics (3 urban, 2 rural), Portland USA, 2002-3
Interventions 1. Depression decision support (n = 189)
Mental health specialist/consumer: the Depression Support Team nurse called the con-
sumer 1 to 2 weeks after enrolment to discuss education, barriers, adherence, and com-
municating with the primary care provider. Consumers were also mailed educational
materials and invited to a two-hour depression education programme. For 76% of con-
sumers this was only contact with mental health specialists; psychiatrists met with 13%
and rang 1%; education sessions attended by 8%
Mental health specialist/primary care provider: all primary care providers were also of-
fered two four-hour training sessions in the recognition and management of depression
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(communication, skills and knowledge). A treatment progress report based on monthly
file review by the decision support team for each consumer was mailed to the primary
care provider every three months. The review considered appointments, medications,
symptom severity, PTSD and alcohol screening. If the primary care provider did not
respond to an initial PHQ-9 score of 15 or more, or the consumer did not improve
over time, the primary care provider was contacted by the team to discuss treatment,
offer psychiatric consultation (with the primary care provider or consumer), or facilitate
referral to ongoing speciality care. The Depression Support Team communicated with
primary care providers or their nurses an average of 2.2 times
Primary care provider/consumer: interaction not reported.
2. Standard care (n = 186)
Mental health specialist/primary care provider:prior to the study, all primary care providers
were offered two four-hour training sessions in the recognition and management of de-
pression (as were intervention primary care providers). An onsite mental health con-
sultation team was also available. Providers received notification that the consumer was
enrolled in the study and their baseline and follow-up PHQ-9 scores were made available
in patient charts
Mental health specialist/consumer: none aside from depression measurement at baseline,
1, 3, 6, 9 and 12 months
Outcomes 1. Consumer
Symptoms: SCL-20 at 6 and 12 months, Patient Health Questionnaire (PHQ-9) scores
at 1, 3, 6, 9 and 12 months
Health status: health-related Quality of Life Short Form for Veterans (SF-36V) scores at
6 and 12 months
Satisfaction: rated poor to excellent on a five-point Likert scale at 6 and 12 months
Adherence: attended at least three mental health appointments.
Healthcare visits: attended three or more primary care appointments.
2. Provider
Diagnosis: consumers assessed for depression over 12 months.
Prescribing: prescribed antidepressants.
Adherence: at least one follow-up depression-related action.
Adequate treatment: minimally effective dose for at least 90 days.
Notes SCL-20means and standard errors estimated from graph, PHQ-9 scores but not variance
were also graphed
Diagnosis and provider adherence reported for a subsample not receiving antidepressants
at the beginning of the study
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified randomisation ’using a random-
number generator’ by clinician to ensure
distribution across type of clinician, clinic
site and caseload
Allocation concealment (selection bias) Unclear risk Not reported.
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Blinding (performance bias and detection
bias)
All outcomes
High risk Data was collected by a blinded research as-
sistant via phone or posted questionnaires,
however data were self-reported and both
consumers and providers are likely to have
been aware whether they were in the active
group
Incomplete outcome data (attrition bias)
All outcomes
High risk Data were reported for those available at
follow-up, loss to follow-up at 6 months
16%, 12 months 15%
Selective reporting (reporting bias) Unclear risk SF-36V scores were not reported, diagno-
sis, referrals and healthcare visits reported
for subsample
Other bias Unclear risk More participants in the standard care
group had PTSD (44% vs 35%)
Drummond 1990
Methods Randomised controlled trial of consultation liaison compared to standard care
Participants Consumers (n = 40): problem drinkers attending an alcohol clinic in the UK. The mean
age was 39 years and 75% were male. Based on the General Health Questionnaire 45%
were considered severe cases
Excluded: not stated.
Primary care providers: GPs of consumers attending the clinic.
Mental health specialists (n = 4): alcohol addiction specialists including three psychiatrists
and one clinical nurse specialist
Setting: GP practices in the UK.
Interventions 1. Consultation Liaison (n = 20)
Mental health specialist/consumer: all consumers received a full psychiatric and physical
assessment, counselled and given advice about their drinking problem and returned to
their GP with assurances that the specialist would remain in contact with their GP
Mental health specialist/primary care provider: specialists visited the GP to discuss man-
agement of the consumer and provided a booklet of guidelines on the management of
alcohol problems. The mental health specialist offered further advice and support to the
GP, initiated further contact by phone to check on progress or difficulties, and provided
a contact phone number
Primary care provider/consumer: interaction not reported.
2. Standard care (n = 20)
Mental health specialist/consumer: people in the standard care group also received a full
psychiatric and physical assessment, and counselling and advice about their drinking
problem (as with the intervention group). They continued to receive routine outpatient
clinic care through the alcohol clinic and, if necessary, admission to hospital
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Outcomes 1. Consumer
Symptoms: Alcohol Problems Questionnaire (APQ, 23 items) at six months
General Health: General Health Questionnaire at six months.
Adherence: complete abstinence over six months.
Healthcare visits: attended GP during six months.
2. Provider
No provider outcomes were reported.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomised by consumer, stratified on
two-level measure of dependence
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
All outcomes
Low risk Follow-up conducted by ’research work-
ers who were not blinded’ but responses
were self-reported; however, as the interac-
tion between consumers and specialists was
similar it is unlikely whether participants
knew theywere in an active or standard care
group
Incomplete outcome data (attrition bias)
All outcomes
High risk Data were reported for those available at
follow-up, loss to follow-up 8%
Selective reporting (reporting bias) Unclear risk The reported APQ score was derived from
23 items ’applicable to all subjects’ rather
than all 46 items
Other bias Unclear risk There were differences between groups in
age, time in present accommodation and
time till follow-up
Hedrick 2003
Methods Randomised trial of consultation liaison compared to collaborative care
Participants Consumers (n = 354): consumers who had been identified as having depression or dys-
thymia in two other studies, through a check-in survey, or by referral from their primary
care provider. The mean age was 57.2 years, 95.5% were male, 79.7% were white, 53.
6% had had previous depression, 59.7% had major depression and 60.7% had both
depression and dysthymia
Excluded: consumers with recent or scheduled mental health clinic appointments, re-
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quiring treatment for substance use or PTSD, suicidality, psychosis or other condition
requiring immediate treatment
Primary care providers (n = 67): doctors (19 physicians, 38 residents, 10 fellows) and 22
nurse practitioners working for the General Internal Medicine Clinic. All were provided
with three hours education on depression assessment, treatment and resources
Mental health specialists (n > 10): CL team included a full-time psychiatry resident,
psychiatrist consultant, clinical psychologists and interns, four social workers and interns
Setting: Veteran’s Affairs clinics, 1998-9 USA.
Interventions 1. Consultation Liaison (n = 186)
Mental health specialist/consumer: mental health specialists provided treatment directly to
consumers in the primary care setting if appropriate or they were referred to speciality
mental health clinics
Mental health specialist/primary care provider:mental health specialist clinicians informed
primary care provider of consumer diagnosis and facilitated referral to psychiatry resi-
dents, psychologist and/or social workers within the clinic. Primary care providers con-
sulted with, or referred to Mental health specialists ‘as deemed necessary’
Consumer/Primary care provider: primary care provider responsible for initiating treat-
ment and co-ordinating consumers’ overall care. Primary care providers also able to refer
to psychologists and social workers working at clinic
2. Collaborative care (n = 168)
Collaborative care team (n > 5) included a clinical psychologist, psychiatrist, social work-
ers and “psychology technician”
Mental health specialist/consumer: treatment options included medication, six sessions
of group CBT, and referral to speciality care. The social worker or students contacted
consumers on a ‘regular schedule’ to encourage adherence, address treatment barriers
and assess response. All consumers received a video and workbook
Mental health specialist/primary care provider: the collaborative care mental health team
informed the primary care provider of the consumer’s diagnosis, provided a treatment
plan, consulted on any disagreements over treatment, monitored primary care provider
adherence to the plan, reviewed treatment results and communicated with the primary
care provider via electronic progress notes. Primary care providers were also able to refer
to psychologists and social workers working at the clinic
Outcomes 1. Consumer
Improvement: 50% reduction in SCL-20 score.
Symptoms: Hopkins SCL-20 depression scale, Veterans Short Form (SF)-36 mental com-
ponent summary at three and nine months
Satisfaction: Consumer satisfaction scale (five items) at three and nine months
Diability: Sheehan Disability Scale (three items) at three and nine months
2. Provider
Prescribing: consumers prescribed antidepressants over nine months, consumers pre-
scribed minimum therapeutic dose of antidepressants over nine months
Cost: Total cost per consumer over nine months.
Notes Note: the SCL-20 average item score was reported.
The number of consumers that no longer had SCL-20 cutoff scores for major depression
of more than 1.75 were also reported but because this was a subset of all consumers 50%
change from baseline scores were used for improvement
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Consumers were randomised by the Gen-
eral Internal Medicine Clinic, sequence
generation not described
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
All outcomes
High risk Consumer outcome measures were admin-
istered by graduate students who were not
informed of a participant’s group member-
ship; however, outcomes were self-reported
and participants in the CC group were
probably aware they were receiving special-
ist treatment
Incomplete outcome data (attrition bias)
All outcomes
High risk Data were reported for those available
at follow-up, loss to follow-up at three
months 7%, nine months 8%
Selective reporting (reporting bias) Unclear risk The decision to report the number of con-
sumers prescribed antidepressants (but not
the number receiving therapeutic doses)
may have been post hoc
Other bias Unclear risk The collaborative care group were more
likely to have previous depression (59.5%
vs 48.4%) and to have major depression
(65% vs 55%)
Katon 1992
Methods Randomised controlled trial of consultation liaison compared to standard care
Participants Consumers (n = 251): people aged 18 to 75 years who were high utilisers of primary care
and identified with anxiety, depression, or somatisation by the SCL-90-R. Their mean
age was 47 years, 39% were male, 24% currently had major depression, and 68% had a
lifetime history of major depression
Excluded: people with current alcohol abuse, psychotic symptoms, serious suicidality,
dementia, limited English, or plan to discontinue health insurance
Primary care providers (n = 18): board-certified family physicians and internists.
Mental health specialists (n = 2): psychiatrists.
Setting: two primary care clinics in Washington state, US.
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Interventions 1. Consultation Liaison (n = 124)
Mental health specialist/consumer: the psychiatrist provided a one hour assessment inter-
view during which the Mental Health Diagnostic Interview Schedule was administered.
Psychiatric diagnoses over the past month were made according to DSM-III-R criteria.
A half-hour interview was then conducted by the psychiatrist with the consumer and
primary care provider present. During this interview the psychiatrist reviewed the con-
sumer’s psychiatric status and social developmental history and a treatment plan was
formulated by all three participants
Mental health specialist/primary care provider: the psychiatrist and primary care provider
jointly formulated a treatment plan with the consumer during the 30-minute joint
interview. There was one additional case conference between the psychiatrist and GP
to review the management of each consumer. The primary care provider was provided
with a written psychiatric consultation, treatment protocol and an article on treatment
for the specific disorder. The psychiatrist reviewed information from the medical charts,
primary care provider and consumers and immediately after consultation filled out a
form listing the identified problems and treatment needs. In 10% of interviews both
psychiatrists were present to ensure uniformity
Primary care provider/consumer: interaction not reported.
2. Standard care (n = 127)
Outcomes 1. Consumer
Consumer adherence: filled one or more prescriptions for antidepressants.
2. Provider
Prescribing: prescribed antidepressants over 12 months.
Adequate treatment: prescribed adequate dosage of antidepressants for at least 90 days
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomised by consumer.
Allocation concealment (selection bias) Unclear risk Not stated.
Blinding (performance bias and detection
bias)
All outcomes
High risk ’Chart reviewers were blind to whether par-
ticipants were in the standard care or inter-
vention group’ but consumers in the con-
sultation liaison group would have known
they were receiving specialist care
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data was available for all participants.
Selective reporting (reporting bias) Unclear risk All outcomes appear to have been reported
but protocol was not available
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Other bias Low risk None identified.
Katon 1995
Methods Randomised controlled trial of consultation liaison compared to standard care
Participants Consumers (n = 217): primary care consumers aged 18 to 80 years who met criteria for
definite or probable major depression (at least 0.75 on the SCL-20 score for depression)
and had agreed to antidepressant therapy. Their mean age was 48 years and 23% were
male, 91 had major depression and 126 had minor depression
Excluded: people with current alcohol abuse, psychotic symptoms, serious suicidality,
dementia, limited English, or plan to discontinue health insurance
Primary care providers (n = 22): board certified family physicians.
Mental health specialists (n = 2): study psychiatrists.
Setting: a large primary care clinic in Washington state, USA.
Interventions 1. Consultation Liaison (n = 108)
Mental health specialist/consumer: consumers were given psychoeducational material prior
to the first visit including a booklet on the biology and medications for depression,
a booklet on CBT for depression, a 20-minute videotape with four doctor-consumer
vignettes, and a questionnaire designed to motivate consumers’ active involvement in
care to take back to the primary care provider. Consumers alternated visits with the
primary care provider (visits one and three) and mental health specialist (visits two and
four) over four to six weeks. The psychiatrist did not do any formal psychotherapy but
helped the primary care provider and consumer with a new medication if there had been
side-effects. Consumers could also refer themselves or be referred by the primary care
provider to a designated mental health clinic
Mental health specialist/primary care provider: primary care providers participated in a
half day didactic on antidepressant and behavioural treatment of depression. Monthly
case conferences and case-by-case consultations were tailored to primary care providers’
queries
Primary care provider/consumer: interaction not reported.
2. Standard care (n = 109)
Consumers received treatment for depression from their primary care provider and, as
with the CL group, could refer themselves or be referred by the primary care provider to
a designated mental health clinic
Outcomes 1. Consumer
Improved: more than 50% decrease from baseline SCL-90 at 4 months.
Symptoms: SCL-90 (self-report) at 1, 4, 7 months but were reported in a graph
Adherence: automated pharmacy data over 90 days.
Satisfaction: five-point ordinal scale at four months.
Healthcare visits: over 12 months.
2. Provider
No provider outcomes were reported.
Notes Because SCL-90 scores were reported in a low resolution graph, these data could not be
used
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified randomisation of consumers
based on severe or moderate depression was
computer-generated
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
All outcomes
High risk Consumers were assessed by ’telephone in-
terview survey team blinded to the con-
sumers’ randomisation status’; however,
outcomes were self-reported and partici-
pants would have been aware they were re-
ceiving specialist treatment
Incomplete outcome data (attrition bias)
All outcomes
High risk Data were reported for those available at
follow-up, loss to follow-up at one month
8%, four months 11%, seven months 15%
Selective reporting (reporting bias) Unclear risk IDS scores were not reported by group.
Other bias Unclear risk Insufficient information, appeared to be
more females in standard care group
Katon 1999
Methods Randomised controlled trial of consultation liaison versus standard care
Participants Consumers (n = 228): consumers aged 18 to 80 years receiving a new prescription for
antidepressants, and identified at risk for persistent depression by four or more major
depressive symptoms on the Structured Clinical Interview for DSM-III-R and a score
of at least one on the SCL-20, or a score of 1.5 or more on the SCL-20. Their mean age
was 47 years and 25% were males, 80% had recurrent depression (at least three episodes)
, 55% had dysthymia and 10% had panic disorder
Excluded: alcohol misuse, pregnancy or nursing, seeing a psychiatrist, using lithium or
an antipsychotic, limited English, or plan to discontinue health insurance
Primary care providers (n = 73): board-certified family physicians.
Mental health specialists (n not known): psychiatrists.
Setting: four large primary care clinics in Washington, USA.
Interventions 1. Consultation Liaison (n = 114)
Mental health specialist/consumer: two sessions were scheduled with the psychiatrist over
four weeks with a brief phone call in between visits to review progress. The psychiatrist
reviewed the course of the current episode; individual, family and psychosocial history;
and current medication. Additional visits could be provided based on clinical response
to treatment. Participants were also given a book and videotape about depression and
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being an active participant in their care with the primary care provider
Mental health specialist/primary care provider: physicians received immediate verbal con-
sultation about the consumer’s progress and typed physician notes within one week. The
psychiatrist reviewed medication compliance and alerted the Primary care provider of
premature discontinuation
Primary care provider/consumer: interaction not reported.
2. Standard care (n = 114)
Consumer/primary care provider: treatment typically involved prescription of medication
over the first three months plus the option of referral to a mental health service
Outcomes 1. Consumer
Improvement: 0 to 1 symptoms on the 9-symptom Structured Clinical Interview for
DSM-IV at three and six months
Symptoms: SCL-90 at one, three, and six months.
Adherence: self-reported adherence to antidepressant therapy for 25 of the previous 30
days at one, three, and six months
Satisfaction: with treatment for depression on a five-point ordinal scale at three and six
months
Healthcare visits: at three and six months.
2. Provider
Adequate treatment: prescribed therapeutic dose of antidepressant for at least 90 days -
identified from computerised pharmacy records
Notes Symptom scores were estimated from graphs but data were skewed
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated block randomisation
of consumers was used
Allocation concealment (selection bias) Unclear risk Not described.
Blinding (performance bias and detection
bias)
All outcomes
High risk Consumer outcomeswere collected by tele-
phone interviewers blind to randomisation
status; however, these were self-reported
and consumers would have been aware they
were receiving specialist treatment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Imputed data were used for analyses but
loss to follow-up at one month was 8%,
three months 15%, and six months 16%
Selective reporting (reporting bias) Unclear risk All outcomes appear to have been reported
but protocol was not available
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Other bias Unclear risk There were more females in the standard
care group (82% vs 68%)
Schrader 2005
Methods Cluster-randomised controlled trial of consultation liaison compared to standard care
Participants Consumers (n = 669): consumers hospitalised for a range of cardiac conditions and
identified as depressed (CES-D score of 16 or more). They were aged 18 to 84 years,
62% were male, and 45% had moderate to severe depression
Exclusions: severe cognitive or physical impairment, participants in other trials, limited
English
Primary care providers (n = 480): GPs.
Mental health specialists (n not known): psychiatric registrars, psychiatrist and cardiac
rehabilitation nurse
Setting: consumers were enrolled from four urban hospitals in Adelaide, Australia 2000-
2001 but consultation liaison care was delivered in conjunction with the consumer’s GP
Interventions 1. Consultation Liaison (n = 331)
Mental health specialist/consumer: consumers were referred to the psychiatric CL unit
while in hospital for a consultation of 20-30 minutes with the psychiatric registrar and
cardiac rehabilitation nurse
Mental health specialist/primary care provider: GPs were invited to a 15 to 30 minute
phone case conference with the attending psychiatric registrar and cardiac rehabilitation
nurse. If this was not possible, the GP was offered a 5 to 10 minute phone call with a
psychiatrist whohadnot seen the consumer formanagement suggestions. The consumer’s
depression scores and guide for the recognition and treatment of depression (medication
and CBT) was sent to all participating GPs. The percentage of GPs participating in
the case conference was 24%, receiving a call from the psychiatrist was 40%, and just
received the consumer’s scores and treatment guide was 36%
Primary care provider/consumer: interaction not reported.
2. Standard care (n = 338)
Consumers in the standard care group received usual cardiac and non-cardiac care in the
hospital and community
Outcomes 1. Consumer
Improved: no longer categorised as depressed according to CES-D scores at 12 months
Health: SF-36 physical health subscale at 12 months.
2. Provider
No provider outcomes were reported.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk ’Centrally randomised’ by GP.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding (performance bias and detection
bias)
All outcomes
High risk Blinding was not described but consumers
were probably aware they were in the active
group
Incomplete outcome data (attrition bias)
All outcomes
High risk Loss to follow-up was very high (33%).
Selective reporting (reporting bias) High risk Did not report SF-36 mental health scores.
Other bias Low risk None identified.
Van der Feltz 2006
Methods Cluster-randomised trial of consultation liaison compared to standard care
Participants Consumers (n = 81): consumers from GP practices who wanted to continue diagnostic
procedures despite persistent symptoms which remained unexplained by previous spe-
cialist diagnostic tests. Their mean age was 44 years, 68 were caucasian and 62 were
female. Seventy were given a comorbid psychiatric diagnosis: 20 with generalised anxiety
disorder, eight with anxiety disorder, seven panic disorder, 15 depression, and 20 with
personality disorder
Excluded: psychosis, suicidality, dementia, alcohol dependency, current psychiatric treat-
ment, younger than18 or unable to complete questionnaire
Primary care providers (n = 58): GPs.
Mental health specialist (n = 1): a consultant psychiatrist.
Setting: 36 GP practices in the Netherlands.
Interventions 1. Consultation Liaison (n = 58)
Mental health specialist/consumer: during the one hour consultation where the GP was
present the psychiatrist aimed to identify a comorbid psychiatric diagnosis requiring
medication as well as disorders requiring CBT or other psychotherapeutic interventions.
Consumers without psychiatric diagnoses received explanations that may explain their
symptoms and were advised to start psychotherapy. The consumer was given copies of
the psychiatrist’s recommendations
Mental health specialist/primary care provider: GPs were given training in case manage-
ment and CBT techniques over three to nine three-hour sessions. GPs also received case
management advice and were given copies of the psychiatrist’s recommendations
2. Primary care provider/consumer: interaction not reported.
Standard care (n = 23).
Mental health specialist/primary care provider: GPs also received training but no consul-
tation.
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Outcomes 1. Consumer
Symptoms: SCL-90-R at six weeks and six months.
Disability: Sickness Impact Profile at six weeks and six months.
Healthcare visits: visits to doctors and other health care services over six months
2. Provider
No provider outcomes were reported.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Practices were randomly assigned by a re-
search assistant.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding (performance bias and detection
bias)
All outcomes
High risk Outcomes were recorded by a blinded re-
search assistant but they were self-reported
and participants would have been aware
they were receiving specialist treatment
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up.
Selective reporting (reporting bias) High risk The SCL-90-R results were not reported
because ’changes -- were not significant’
Other bias High risk Although practices were randomly allo-
cated the much higher number of con-
sumers in the intervention group (58 vs 23)
may indicate biases in the detection of dis-
orders
Worrall 1999
Methods Cluster-randomised controlled trial of consultation liaison compared to guidelines only
Participants Consumers (n = 147): consumers with newly diagnosed depression.
Excluded: not described.
Primary care providers (n = 42): family physicians (only one per practice was included).
Mental health specialists (n = 2): a psychiatrist and academic family physician.
Setting: 42 General practices in Canada in 1997.
Interventions 1. Consultation Liaison (n = 91)
Mental health specialist/consumer: no interaction reported.
Mental health specialist/primary care provider: GPs attended three hour workshops deliv-
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ered by a psychiatrist and academic family physician. The workshop covered the epi-
demiology and explanation of clinical practice guidelines developed by the Canadian
Medical Association for depression and included case discussions. GPs could discuss
their own cases with reference to diagnosis and treatment difficulties. A psychiatrist was
available for advice on patient management at a specific time each week
2. Guidelines only (n = 56)
GPs were mailed a copy of clinical practice guidelines with no specific instruction on
their use
Outcomes 1. Consumer
Symptoms: CES-D at six months.
Adherence: took antidepressant for six months.
Healthcare visits: to primary care physician over six months.
2. Provider
Diagnosis: correct DSM-IV diagnoses over six months.
Prescribing: prescribed antidepressants at first visit.
Specialist treatment: referrals to mental health professionals over six months.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ’Physicians were assigned to the interven-
tion or standard care group by the use of
random number tables’
Allocation concealment (selection bias) Unclear risk Not described.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding was not described; however, con-
sumer participantswere probably not aware
of whether they were in the active or stan-
dard care group as there was no direct in-
teraction with a mental health specialist re-
ported. Primary care providers would have
been aware which group they had been al-
located to
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Participant numbers for all outcomes may
be incorrect as the loss to follow-up was not
reported and ’not all patients completed the
CES-D at 6 months’
Selective reporting (reporting bias) High risk The results for the SCL-90-R, which was a
primary outcome, were not reported
Other bias High risk Although physicians were randomly allo-
cated, the higher number of consumers in
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the intervention group (91 vs 56) may in-
dicate biases in the detection of depression.
Cluster randomisation does not seem to
have been accounted for in the analysis
APQ: Alcohol Problems Questionnaire
CBT: Cognitive Behavioural therapy
CES-D: Centre for Epidemiological Studies Depression Scale
CIDI: Composite International Diagnostic Interview
DSM: Diagnostic and Statistical Manual of Mental Disorders
GHQ: General Health Questionnaire
GP: General practitioner
IDS: Inventory for Depressive Symptomatology
PHQ: Patient Health Questionnaire
PTSD: Posttraumatic Stress Disorder
SCL: Hopkins Symptoms checklist
SF-36V: Short Form for Veterans
WHO: World Health Organization
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Arora 2011 Implementation of a telemedicine project, not mental health-specific
Baker 2001 Guideline implementation study.
Bauer 2011 Study of collaborative care.
Bogner 2012 Study of collaborative care.
Carr 1997 Controlled before and after study, did not have two intervention and two control sites
Chung 2011 Quality Improvement programme based on training and discussion lists
Dietrich 2004 Study of collaborative care.
Harvey 2012 Pre-post study with one measure at each interval.
Horner 2005 Study of collaborative care.
Liu 2007 Patients were being managed in general medical clinic in a general hospital
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(Continued)
Llewellyn-Jones 1999 Shared care intervention.
Menchetti 2007 Whether treatment was delivered by primary care providers, the consultant
psychiatrist, community mental health centre, or a combination of these was based on a treatment algorithm
Serrano 2011 Study of collaborative care.
Sherbourne 2001 Trial of recommendations to use psychotherapy or medications compared to standard care
Sinnema 2011 Study of interventions to improve guideline implementation.
Stiefel 2008 Patient participants had a complex medical illness not a mental disorder
Su 2011 Chart review of consultation liaison service in a general hospital
Tello-Bernabe 2011 Implementation of Clinical Practice Guidelines.
Wells 1999 Interaction between mental health specialist and primary care provider was educational not consultative
Wiener 2006 Before and after study of consultation liaison utilisation and satisfaction
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D A T A A N D A N A L Y S E S
Comparison 1. Consultation liaison versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Improvement 3 Risk Difference (M-H, Random, 95% CI) Subtotals only
1.1 up to 3 months 2 445 Risk Difference (M-H, Random, 95% CI) 0.13 [0.04, 0.22]
1.2 from 3 to 12 months 2 678 Risk Difference (M-H, Random, 95% CI) 0.06 [-0.05, 0.18]
2 Symptoms 3 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 from 3 to 12 months 3 546 Std. Mean Difference (IV, Random, 95% CI) -0.15 [-0.32, 0.03]
3 Consumer satisfaction 2 Risk Difference (M-H, Random, 95% CI) Subtotals only
3.1 up to 3 months 1 228 Risk Difference (M-H, Random, 95% CI) 0.31 [0.21, 0.40]
3.2 from 3 to 12 months 2 445 Risk Difference (M-H, Random, 95% CI) 0.12 [0.06, 0.19]
4 Consumer adherence 7 Risk Difference (M-H, Random, 95% CI) Subtotals only
4.1 up to 3 months 1 228 Risk Difference (M-H, Random, 95% CI) 0.08 [-0.04, 0.19]
4.2 from 3 to 12 months 7 1251 Risk Difference (M-H, Random, 95% CI) 0.16 [0.08, 0.24]
4.3 more than 12 months 1 53 Risk Difference (M-H, Random, 95% CI) 0.03 [-0.22, 0.27]
5 Disability 1 Mean Difference (IV, Random, 95% CI) Totals not selected
5.1 up to 3 months 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
5.2 from 3 to 12 months 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
6 Healthcare visits 1 Mean Difference (IV, Random, 95% CI) Totals not selected
6.1 from 3 to 12 months 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
7 People lost to follow-up 7 Risk Difference (M-H, Random, 95% CI) Subtotals only
7.1 up to 3 months 1 84 Risk Difference (M-H, Random, 95% CI) -0.05 [-0.19, 0.09]
7.2 from 3 to 12 months 7 1544 Risk Difference (M-H, Random, 95% CI) 0.00 [-0.03, 0.04]
7.3 more than 12 months 1 67 Risk Difference (M-H, Random, 95% CI) 0.10 [-0.12, 0.31]
8 Diagnosis 1 Risk Difference (M-H, Random, 95% CI) Totals not selected
8.1 from 3 to 12 months 1 Risk Difference (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
9 Received any treatment 1 Risk Difference (M-H, Random, 95% CI) Totals not selected
9.1 from 3 to 12 months 1 Risk Difference (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
10 Received adequate treatment 3 Risk Difference (M-H, Random, 95% CI) Subtotals only
10.1 from 3 to 12 months 3 797 Risk Difference (M-H, Random, 95% CI) 0.15 [0.06, 0.24]
11 Specialist treatment 2 Risk Difference (M-H, Random, 95% CI) Subtotals only
11.1 from 3 to 12 months 2 227 Risk Difference (M-H, Random, 95% CI) 0.05 [-0.10, 0.20]
12 Prescribing 5 Risk Difference (M-H, Random, 95% CI) Subtotals only
12.1 from 3 to 12 months 4 796 Risk Difference (M-H, Random, 95% CI) 0.08 [0.02, 0.15]
12.2 more than 12 months 1 48 Risk Difference (M-H, Random, 95% CI) 0.02 [-0.25, 0.30]
13 Primary care provider
adherence
1 Risk Difference (M-H, Random, 95% CI) Totals not selected
13.1 from 3 to 12 months 1 Risk Difference (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 2. Consultation liaison versus collaborative care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Improvement 1 Risk Difference (M-H, Fixed, 95% CI) Totals not selected
1.1 up to 3 months 1 Risk Difference (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 from 3 to 12 months 1 Risk Difference (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Symptoms 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 up to 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 from 3 to 12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Consumer satisfaction 1 Risk Difference (M-H, Fixed, 95% CI) Totals not selected
3.1 up to 3 months 1 Risk Difference (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 from 3 to 12 months 1 Risk Difference (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Disability 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 up to 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 from 3 to 12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 General health 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 up to 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 from 3 to 12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Loss to follow-up 1 Risk Difference (M-H, Fixed, 95% CI) Totals not selected
6.1 up to 3 months 1 Risk Difference (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 from 3 to 12 months 1 Risk Difference (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Received adequate treatment 1 Risk Difference (M-H, Fixed, 95% CI) Totals not selected
7.1 from 3 to 12 months 1 Risk Difference (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Prescribing 1 Risk Difference (M-H, Fixed, 95% CI) Totals not selected
8.1 from 3 to 12 months 1 Risk Difference (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
51Consultation liaison in primary care for people with mental disorders (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.1. Comparison 1 Consultation liaison versus control, Outcome 1 Improvement.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 1 Consultation liaison versus control
Outcome: 1 Improvement
Study or subgroup Consultation Liaison Control
Risk
Difference Weight
Risk
Difference
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 up to 3 months
Katon 1995 72/108 64/109 46.6 % 0.08 [ -0.05, 0.21 ]
Katon 1999 46/114 26/114 53.4 % 0.18 [ 0.06, 0.29 ]
Subtotal (95% CI) 222 223 100.0 % 0.13 [ 0.04, 0.22 ]
Total events: 118 (Consultation Liaison), 90 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 1.16, df = 1 (P = 0.28); I2 =14%
Test for overall effect: Z = 2.73 (P = 0.0064)
2 from 3 to 12 months
Katon 1999 50/114 35/114 43.5 % 0.13 [ 0.01, 0.26 ]
Schrader 2005 86/213 93/237 56.5 % 0.01 [ -0.08, 0.10 ]
Subtotal (95% CI) 327 351 100.0 % 0.06 [ -0.05, 0.18 ]
Total events: 136 (Consultation Liaison), 128 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 2.35, df = 1 (P = 0.13); I2 =57%
Test for overall effect: Z = 1.07 (P = 0.29)
Test for subgroup differences: Chi2 = 0.77, df = 1 (P = 0.38), I2 =0.0%
-0.5 -0.25 0 0.25 0.5
Favours control Favours CL
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Analysis 1.2. Comparison 1 Consultation liaison versus control, Outcome 2 Symptoms.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 1 Consultation liaison versus control
Outcome: 2 Symptoms
Study or subgroup Consultation Liaison Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 from 3 to 12 months
Datto 2003 35 14.8 (11.2) 37 19.3 (10.3) 13.7 % -0.41 [ -0.88, 0.05 ]
Dobscha 2006 163 1.54 (0.64) 164 1.58 (0.74) 59.9 % -0.06 [ -0.27, 0.16 ]
Worrall 1999 91 19.4 (13.6) 56 22.2 (11.7) 26.4 % -0.22 [ -0.55, 0.12 ]
Subtotal (95% CI) 289 257 100.0 % -0.15 [ -0.32, 0.03 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 2.07, df = 2 (P = 0.36); I2 =3%
Test for overall effect: Z = 1.67 (P = 0.096)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours CL Favours control
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Analysis 1.3. Comparison 1 Consultation liaison versus control, Outcome 3 Consumer satisfaction.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 1 Consultation liaison versus control
Outcome: 3 Consumer satisfaction
Study or subgroup Consultation Liaison Control
Risk
Difference Weight
Risk
Difference
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 up to 3 months
Katon 1999 108/114 73/114 100.0 % 0.31 [ 0.21, 0.40 ]
Subtotal (95% CI) 114 114 100.0 % 0.31 [ 0.21, 0.40 ]
Total events: 108 (Consultation Liaison), 73 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 6.19 (P < 0.00001)
2 from 3 to 12 months
Katon 1995 101/108 91/109 65.4 % 0.10 [ 0.02, 0.18 ]
Katon 1999 91/114 72/114 34.6 % 0.17 [ 0.05, 0.28 ]
Subtotal (95% CI) 222 223 100.0 % 0.12 [ 0.06, 0.19 ]
Total events: 192 (Consultation Liaison), 163 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.94, df = 1 (P = 0.33); I2 =0.0%
Test for overall effect: Z = 3.57 (P = 0.00036)
Test for subgroup differences: Chi2 = 9.25, df = 1 (P = 0.00), I2 =89%
-0.5 -0.25 0 0.25 0.5
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Analysis 1.4. Comparison 1 Consultation liaison versus control, Outcome 4 Consumer adherence.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 1 Consultation liaison versus control
Outcome: 4 Consumer adherence
Study or subgroup Consultation Liaison Control
Risk
Difference Weight
Risk
Difference
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 up to 3 months
Katon 1999 88/114 79/114 100.0 % 0.08 [ -0.04, 0.19 ]
Subtotal (95% CI) 114 114 100.0 % 0.08 [ -0.04, 0.19 ]
Total events: 88 (Consultation Liaison), 79 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.35 (P = 0.18)
2 from 3 to 12 months
De Cruppe 2005 8/27 5/26 8.3 % 0.10 [ -0.13, 0.33 ]
Dobscha 2006 37/164 25/154 20.3 % 0.06 [ -0.02, 0.15 ]
Drummond 1990 3/18 2/19 8.8 % 0.06 [ -0.16, 0.28 ]
Katon 1992 65/124 46/127 16.5 % 0.16 [ 0.04, 0.28 ]
Katon 1995 84/108 48/109 16.5 % 0.34 [ 0.22, 0.46 ]
Katon 1999 90/114 71/114 17.0 % 0.17 [ 0.05, 0.28 ]
Worrall 1999 51/91 22/56 12.6 % 0.17 [ 0.00, 0.33 ]
Subtotal (95% CI) 646 605 100.0 % 0.16 [ 0.08, 0.24 ]
Total events: 338 (Consultation Liaison), 219 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 14.07, df = 6 (P = 0.03); I2 =57%
Test for overall effect: Z = 3.89 (P = 0.000099)
3 more than 12 months
De Cruppe 2005 8/27 7/26 100.0 % 0.03 [ -0.22, 0.27 ]
Subtotal (95% CI) 27 26 100.0 % 0.03 [ -0.22, 0.27 ]
Total events: 8 (Consultation Liaison), 7 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.22 (P = 0.83)
Test for subgroup differences: Chi2 = 1.93, df = 2 (P = 0.38), I2 =0.0%
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Analysis 1.5. Comparison 1 Consultation liaison versus control, Outcome 5 Disability.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 1 Consultation liaison versus control
Outcome: 5 Disability
Study or subgroup Consultation Liaison Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 up to 3 months
Van der Feltz 2006 58 15.3 (16.3) 23 29.4 (22.8) -14.10 [ -24.32, -3.88 ]
2 from 3 to 12 months
Van der Feltz 2006 58 10.8 (13.9) 23 26.8 (21.7) -16.00 [ -25.56, -6.44 ]
-50 -25 0 25 50
Favours CL Favours control
Analysis 1.6. Comparison 1 Consultation liaison versus control, Outcome 6 Healthcare visits.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 1 Consultation liaison versus control
Outcome: 6 Healthcare visits
Study or subgroup Favours CL Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 from 3 to 12 months
Katon 1995 108 4.5 (3.7) 109 3.7 (2.4) 0.80 [ -0.03, 1.63 ]
-2 -1 0 1 2
Favours CL Favours control
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Analysis 1.7. Comparison 1 Consultation liaison versus control, Outcome 7 People lost to follow-up.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 1 Consultation liaison versus control
Outcome: 7 People lost to follow-up
Study or subgroup Consultation Liaison Control
Risk
Difference Weight
Risk
Difference
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 up to 3 months
Datto 2003 4/42 6/42 100.0 % -0.05 [ -0.19, 0.09 ]
Subtotal (95% CI) 42 42 100.0 % -0.05 [ -0.19, 0.09 ]
Total events: 4 (Consultation Liaison), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
2 from 3 to 12 months
Datto 2003 7/42 6/42 5.1 % 0.02 [ -0.13, 0.18 ]
De Cruppe 2005 6/33 8/34 3.2 % -0.05 [ -0.25, 0.14 ]
Dobscha 2006 26/189 33/186 22.3 % -0.04 [ -0.11, 0.03 ]
Drummond 1990 2/20 1/20 4.6 % 0.05 [ -0.11, 0.21 ]
Katon 1999 27/114 34/114 9.2 % -0.06 [ -0.18, 0.05 ]
Schrader 2005 118/331 101/338 24.0 % 0.06 [ -0.01, 0.13 ]
Van der Feltz 2006 0/58 0/23 31.7 % 0.0 [ -0.06, 0.06 ]
Subtotal (95% CI) 787 757 100.0 % 0.00 [ -0.03, 0.04 ]
Total events: 186 (Consultation Liaison), 183 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 5.60, df = 6 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 0.06 (P = 0.95)
3 more than 12 months
De Cruppe 2005 11/33 8/34 100.0 % 0.10 [ -0.12, 0.31 ]
Subtotal (95% CI) 33 34 100.0 % 0.10 [ -0.12, 0.31 ]
Total events: 11 (Consultation Liaison), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.89 (P = 0.37)
Test for subgroup differences: Chi2 = 1.26, df = 2 (P = 0.53), I2 =0.0%
-1 -0.5 0 0.5 1
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Analysis 1.8. Comparison 1 Consultation liaison versus control, Outcome 8 Diagnosis.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 1 Consultation liaison versus control
Outcome: 8 Diagnosis
Study or subgroup Consultation Liaison Control
Risk
Difference
Risk
Difference
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 from 3 to 12 months
Worrall 1999 84/91 53/56 -0.02 [ -0.10, 0.06 ]
-0.2 -0.1 0 0.1 0.2
Favours control Favours CL
Analysis 1.9. Comparison 1 Consultation liaison versus control, Outcome 9 Received any treatment.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 1 Consultation liaison versus control
Outcome: 9 Received any treatment
Study or subgroup Consultation Liaison Control
Risk
Difference
Risk
Difference
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 from 3 to 12 months
Berti Ceroni 2002 18/36 26/44 -0.09 [ -0.31, 0.13 ]
-0.5 -0.25 0 0.25 0.5
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Analysis 1.10. Comparison 1 Consultation liaison versus control, Outcome 10 Received adequate
treatment.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 1 Consultation liaison versus control
Outcome: 10 Received adequate treatment
Study or subgroup Consultation Liaison Control
Risk
Difference Weight
Risk
Difference
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 from 3 to 12 months
Dobscha 2006 118/164 90/154 33.2 % 0.14 [ 0.03, 0.24 ]
Katon 1992 23/124 12/127 39.3 % 0.09 [ 0.01, 0.18 ]
Katon 1999 78/114 50/114 27.5 % 0.25 [ 0.12, 0.37 ]
Subtotal (95% CI) 402 395 100.0 % 0.15 [ 0.06, 0.24 ]
Total events: 219 (Consultation Liaison), 152 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 4.26, df = 2 (P = 0.12); I2 =53%
Test for overall effect: Z = 3.33 (P = 0.00086)
Test for subgroup differences: Not applicable
-0.5 -0.25 0 0.25 0.5
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Analysis 1.11. Comparison 1 Consultation liaison versus control, Outcome 11 Specialist treatment.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 1 Consultation liaison versus control
Outcome: 11 Specialist treatment
Study or subgroup Consultation Liaison Control
Risk
Difference Weight
Risk
Difference
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 from 3 to 12 months
Berti Ceroni 2002 2/36 4/44 47.3 % -0.04 [ -0.15, 0.08 ]
Worrall 1999 14/91 2/56 52.7 % 0.12 [ 0.03, 0.21 ]
Subtotal (95% CI) 127 100 100.0 % 0.05 [ -0.10, 0.20 ]
Total events: 16 (Consultation Liaison), 6 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 4.38, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.59 (P = 0.55)
Test for subgroup differences: Not applicable
-0.5 -0.25 0 0.25 0.5
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Analysis 1.12. Comparison 1 Consultation liaison versus control, Outcome 12 Prescribing.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 1 Consultation liaison versus control
Outcome: 12 Prescribing
Study or subgroup Consultation Liaison Control
Risk
Difference Weight
Risk
Difference
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 from 3 to 12 months
Berti Ceroni 2002 16/36 17/44 8.4 % 0.06 [ -0.16, 0.27 ]
Dobscha 2006 130/164 108/154 35.1 % 0.09 [ 0.00, 0.19 ]
Katon 1992 65/124 46/127 23.8 % 0.16 [ 0.04, 0.28 ]
Worrall 1999 83/91 50/56 32.7 % 0.02 [ -0.08, 0.12 ]
Subtotal (95% CI) 415 381 100.0 % 0.08 [ 0.02, 0.15 ]
Total events: 294 (Consultation Liaison), 221 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 3.61, df = 3 (P = 0.31); I2 =17%
Test for overall effect: Z = 2.47 (P = 0.013)
2 more than 12 months
De Cruppe 2005 9/22 10/26 100.0 % 0.02 [ -0.25, 0.30 ]
Subtotal (95% CI) 22 26 100.0 % 0.02 [ -0.25, 0.30 ]
Total events: 9 (Consultation Liaison), 10 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.86)
Test for subgroup differences: Chi2 = 0.16, df = 1 (P = 0.69), I2 =0.0%
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Analysis 1.13. Comparison 1 Consultation liaison versus control, Outcome 13 Primary care provider
adherence.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 1 Consultation liaison versus control
Outcome: 13 Primary care provider adherence
Study or subgroup Consultation Liaison Control
Risk
Difference
Risk
Difference
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 from 3 to 12 months
De Cruppe 2005 12/27 7/26 0.18 [ -0.08, 0.43 ]
-0.5 -0.25 0 0.25 0.5
Favours control Favours CL
Analysis 2.1. Comparison 2 Consultation liaison versus collaborative care, Outcome 1 Improvement.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 2 Consultation liaison versus collaborative care
Outcome: 1 Improvement
Study or subgroup Consultation Liaison Collaborative Care
Risk
Difference
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 up to 3 months
Hedrick 2003 26/172 27/156 -0.02 [ -0.10, 0.06 ]
2 from 3 to 12 months
Hedrick 2003 26/175 27/151 -0.03 [ -0.11, 0.05 ]
-0.5 -0.25 0 0.25 0.5
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Analysis 2.2. Comparison 2 Consultation liaison versus collaborative care, Outcome 2 Symptoms.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 2 Consultation liaison versus collaborative care
Outcome: 2 Symptoms
Study or subgroup Consultation Liaison Collaborative Care
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 up to 3 months
Hedrick 2003 172 -0.14 (0.67) 156 -0.34 (0.62) 0.20 [ 0.06, 0.34 ]
2 from 3 to 12 months
Hedrick 2003 175 -0.25 (0.79) 151 -0.41 (0.61) 0.16 [ 0.01, 0.31 ]
-0.5 -0.25 0 0.25 0.5
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Analysis 2.3. Comparison 2 Consultation liaison versus collaborative care, Outcome 3 Consumer
satisfaction.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 2 Consultation liaison versus collaborative care
Outcome: 3 Consumer satisfaction
Study or subgroup Consultation Liaison Collaborative Care
Risk
Difference
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 up to 3 months
Hedrick 2003 145/172 134/156 -0.02 [ -0.09, 0.06 ]
2 from 3 to 12 months
Hedrick 2003 151/175 130/151 0.00 [ -0.07, 0.08 ]
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Analysis 2.4. Comparison 2 Consultation liaison versus collaborative care, Outcome 4 Disability.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 2 Consultation liaison versus collaborative care
Outcome: 4 Disability
Study or subgroup Consultation Liaison Collaborative Care
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 up to 3 months
Hedrick 2003 172 0.09 (2.36) 156 -0.63 (2.62) 0.72 [ 0.18, 1.26 ]
2 from 3 to 12 months
Hedrick 2003 175 0.05 (2.65) 151 -0.55 (2.58) 0.60 [ 0.03, 1.17 ]
-2 -1 0 1 2
Favours CL Favours CC
Analysis 2.5. Comparison 2 Consultation liaison versus collaborative care, Outcome 5 General health.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 2 Consultation liaison versus collaborative care
Outcome: 5 General health
Study or subgroup Consultation Liaison Collaborative Care
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 up to 3 months
Hedrick 2003 172 1.71 (11) 156 5.06 (12.5) -3.35 [ -5.91, -0.79 ]
2 from 3 to 12 months
Hedrick 2003 175 2.2 (12.8) 151 5.69 (12.8) -3.49 [ -6.28, -0.70 ]
-10 -5 0 5 10
Favours CC Favours CL
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Analysis 2.6. Comparison 2 Consultation liaison versus collaborative care, Outcome 6 Loss to follow-up.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 2 Consultation liaison versus collaborative care
Outcome: 6 Loss to follow-up
Study or subgroup Consultation Liaison Collaborative Care
Risk
Difference
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 up to 3 months
Hedrick 2003 14/186 12/156 0.00 [ -0.06, 0.05 ]
2 from 3 to 12 months
Hedrick 2003 11/186 17/156 -0.05 [ -0.11, 0.01 ]
-0.2 -0.1 0 0.1 0.2
Favours CL Favours CC
Analysis 2.7. Comparison 2 Consultation liaison versus collaborative care, Outcome 7 Received adequate
treatment.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 2 Consultation liaison versus collaborative care
Outcome: 7 Received adequate treatment
Study or subgroup Consultation Liaison Collaborative Care
Risk
Difference
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 from 3 to 12 months
Hedrick 2003 73/175 88/151 -0.17 [ -0.27, -0.06 ]
-0.2 -0.1 0 0.1 0.2
Favours CC Favours CL
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Analysis 2.8. Comparison 2 Consultation liaison versus collaborative care, Outcome 8 Prescribing.
Review: Consultation liaison in primary care for people with mental disorders
Comparison: 2 Consultation liaison versus collaborative care
Outcome: 8 Prescribing
Study or subgroup Consultation Liaison Collaborative Care
Risk
Difference
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 from 3 to 12 months
Hedrick 2003 109/175 121/151 -0.18 [ -0.27, -0.08 ]
-0.5 -0.25 0 0.25 0.5
Favours CC Favours CL
A D D I T I O N A L T A B L E S
Table 1. Symptoms - skewed data
Study Interval group sample n mean SD
Drummond 1990 6 months Consultation liaison 18 4.6 4.7
Control 19 5.4 7.0
Katon 1999 1 month Consultation liaison 114 1.35 1.6
Control 114 1.5 1.5
3 months Consultation liaison 114 1.05 1.6
Control 114 1.35 1.5
6 weeks Consultation liaison 114 1.15 1.6
Control 114 1.3 1.4
Table 2. Healthcare visits - skewed data
Study Interval group sample n mean SD
Drummond 1990 6 months Consultation liaison 18 4.6 6.4
Control 19 1.8 1.8
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Table 2. Healthcare visits - skewed data (Continued)
Katon 1999 6 weeks Consultation liaison 114 1.6 1.8
Control 114 1.8 1.8
6 months Consultation liaison 114 3.4 4.3
Control 114 3.3 3.1
Van der Feltz 2006 6 weeks Consultation liaison 58 44.3 59.3
Control 23 89.2 145.1
6 months Consultation liaison 58 32.7 25.6
Control 23 133.9 219.4
Worrall 1999 6 months Consultation liaison 91 3.6 7.7
Control 56 4.2 7.6
A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1 consultation liaison.ti,ab. [this term is most often associated with a psychiatric model] (1153)
2 ((depression or mental or psych$) adj3 (collaborativ$ or liaison?)).ti,ab. (2495)
3 (psychiatr$ and (general practitioner? or family doctor? or family practitioner? or family doctor? or GP)).ti. (347)
4 (psychiatr$ adj4 (general practitioner? or family doctor? or family practitioner? or family doctor? or GP)).ab. (646)
5 ((psychiatri$ or mental health or depression or depressed) and (general practice? or (primary adj2 care))).ti. (3253)
6 ((psychiatri$ or mental health or depression or depressed) adj6 (general practice? or (primary adj2 care))).ab. (4550)
7 or/1-6 [Keyword Set] (9490)
8 community psychiatry/ or community mental health services/ (17831)
9 (community adj3 (psychiatr$ or mental health)).ti,ab. (7707)
10 or/8-9 [Community Psychiatry] (21868)
11 telepsychiatry.ti,ab. (322)
12 tele-psychiatry.ti,ab. (2)
14 mental health services/ or exp counseling/ or social work, psychiatric/ (60799)
15 psychotherapy/ or behavior therapy/ or cognitive therapy/ (77856)
16 behavioral medicine/ or psychiatry/ or adolescent psychiatry/ or biological psychiatry/ or child psychiatry/ or community psychiatry/
or ethnopsychology/ or geriatric psychiatry/ or neuropsychiatry/ or orthopsychiatry/ or psychoanalysis/ or psychosomatic medicine/
(54791)
17 exp mental disorders/ (957894)
18 (mental$ adj2 (health or ill or illness$ or disorder?)).ti,ab. or (bipolar or depression or schitzophr$ or psychotic or anorex$ or bulimi?
or suicid$).ti. or depressive.ti,ab. (275857)
19 (((mood or anxiety or eating) adj2 disorder?) or (PTSD or post-traumatic stress or bulimi$ or anorexi$)).ti,ab. (78418)
20 or/14-19 [Mental health/disorders/practitioners/therapies] (1191783)
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21 Primary health care/ (55187)
22 Family practice/ or General Practice/ or Primary Care Nursing/ (65614)
23 General Practitioners/ or Physicians, Family/ or Physicians, Primary Care/ (18284)
24 ((general or family) adj2 (practice? or practitioner? or physician? or doctor?)).ti,ab. or GP.ti. (95569)
25 (primary adj2 (care or health care or healthcare or medical care or patient care)).ti,ab. (89077)
26 or/21-25 [Primary Care/Practitioners] (214638)
27 (randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or ran-
domly.ab. or trial.ti. (930250)
28 exp animals/ not humans.sh. (4051829)
29 27 not 28 [Cochrane RCT Filter 6.4.d Sens/Precision Maximizing] (859939)
30 (collaborativ$ or target?ed or multidisciplin$ or multi-disciplin$ or interdisciplin$ or inter-disciplin$ or multi-facet$ or multifacet$
or coordinated or co-ordinated or coordinating or co-ordinating or shared care).ti. (57268)
31 20 and 26 and 29 [Mental Disorders/practitioners & Primary Care & RCT] (4145)
32 (20 and 30 and 29) not 31 [Mental Disorders/practitioners & Collaborative kw & RCT] (414)
33 (and/7,29) not (or/31-32) [Keyword & RCT] (152)
34 ((or/10,13) and (or/26,30) and 29) not (or/31-33) [Telepsych/Community psych & PC or collab kw--RCT] (2)
35 31 or 32 or 33 or 34 (4713)
36 remove duplicates from 35 (3984)
37 review.pt. or ((literature or evidence or systematic) adj3 review).ti. or metaanalys$.ti,hw. or meta-analys$.ti,hw. (1983039)
38 36 and 37 [export as Review set] (352)
39 36 not 38 [Export 2013 ML1.2 results all years deduping will be done in Reference Manager] (3632)
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Sarah Hetrick - study selection, data extraction, wrote the protocol.
D E C L A R A T I O N S O F I N T E R E S T
Donna Gillies - none known.
Penny Buykx - none known.
Alex Parker - none known.
Sarah Hetrick - none known.
68Consultation liaison in primary care for people with mental disorders (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S O U R C E S O F S U P P O R T
Internal sources
• Western Sydney Local Health District - Mental Health, Parramatta, Australia.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The protocol stated that “For CBA studies there needs to be contemporaneous data collection and a control group that is comparable
on key characteristics”; however, these criteria were updated in line with the EPOC data checklist that there had to be at least two
intervention and control sites for the study to be included.
In the protocol it was stated that:
• we would handsearch those high-yield journals and conference proceedings which have not already been handsearched on behalf
of the Cochrane Collaboration;
• we would contact authors of relevant papers regarding any further published or unpublished work;
• we would contact authors of other reviews in the field of effective professional practice regarding relevant studies of which they
may be aware; and
• we would search ISI Web of Science for papers which cite studies included in the review.
However, given the comprehensive search strategy that was available to us these were not done.
The author team and title have changed since the publication of the protocol (Parker 2008).
We had originally stated that we would calculate odds ratios for binary data; however, based on feedback from Peer Reviewers and the
criteria for choosing methods of data synthesis described above, we used Risk Difference instead.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Mental Health; Community Mental Health Services [∗organization & administration]; Depression [diagnosis; therapy]; Mental
Disorders [diagnosis; ∗ therapy]; PatientCare Team [∗organization&administration]; Patient Participation; Physician-Patient Relations;
PrimaryHealthCare [∗organization&administration]; RandomizedControlledTrials as Topic; Referral andConsultation [organization
& administration]
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MeSH check words
Humans
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